79/216 - SEPT/OCT 2024
Are you a healthcare organization accelerating your sustainable practices and seeking formal recognition?
Discover how Joint Commission International (JCI) and the Geneva Sustainable Centre (GSC) can support you on your journey toward sustainable healthcare.
For more information, please scan the QR code.
It is true that health crises are not new to the world, nor are the solutions and efforts that drive towards a healthier world. Rather, the endeavors, innovations, and developments that the world has witnessed continuously have made a huge difference that cannot be passed over as if it were a normal, automatic path in a general context with a known direction.
As health crises intensified around the world, medical and scientific efforts intensified in return. Happy endings were achieved, and appropriate solutions were secured despite the sometimes shallow capabilities compared to the size of the crises and the high costs they require, whether materially or technically.
Today, although the world has relatively gotten rid of the shock of the Covid-19 pandemic and its health, psychological, and economic effects, it has not completely gotten rid of the crises that put pressure on the health sector and require treatment. Perhaps the most prominent of these are two crises: the issues that affect millions of children worldwide - whether as a result of wars or diseases and injuries of all kinds - which leave their profound effects on the future of societies. According to reports issued by the United Nations, the material costs of addressing these crises exceed two billion dollars.
There is no doubt that much is required, but there is also no doubt that the efforts made by those in charge are great and appreciated. With health sector leaders' awareness, great experience, and efforts in this field, the future must be bright, even if the road is winding and the obstacles are accumulating!
The Publisher
Publisher Arab Health Media Communication
President Simon Chammas schammas@tahmag.com
Executive Vice President Mirna Khairallah mirna@tahmag.com
Senior Editor Elham Najem editorial@tahmag.com
Content Executive Jessica Achkar editorial@tahmag.com
Editors Aline Debes, Mark Steven, Don Karn, Andrew Weichert, Colette Semaan, Abbas Moussa
Content Marketing Manager Jessie Chlela jessie@tahmag.com
Creative Director Rania Khalil rania@tahmag.com
Business Development Manager Wadih Chammas wadih@tahmag.com
IT Manager Elie Yammine elie@tahmag.com
Photographer Hanna Nehme
Advertising advertising@thearabhospital.com
OFFICES
IHMC, Cyprus +357 96 158661
Dubai Expert Media Communication Services-FZCO
Dubai Silicone Oasis +971 50 2971007
Printing
Distribution KSA - UAE - OMAN - TURKEY
LEBANON - JORDAN - KUWAIT
BAHRAIN - QATAR - EGYPT
All images from shutterstock© unless provided by clients .
All rights reserved by the HOSPITALS magazine. No part of this publication can be reproduced in any form without prior permission in writting from the publisher.
52 Liv Hospital New Era in Healthcare
80 MEDICA GROUP
Dr. Matteo Vigo, Plastic surgeon, Medical Director at the Amwaj Polyclinic Dubai
100 MEDICA GROUP
Dr. Lyor Hanan, Plastic and Reconstructive Surgeon at Beauté Concept by CSHP in Dubai
8 Joint Commission International, in Collaboration with Geneva Sustainability Centre, Launches New Healthcare Sustainability Certification
10 ADHDS, the operator of Malaffi, takes an International leap with a groundbreaking partnership with Presight to drive digital healthcare transformation in Jordan
96 WCM-Q to host second alumni-led primary care conference
74 Al-Ahli Hospital Qatar: Signs of Root Canal Failure and How to Address Them
84 Al-Ahli Hospital Qatar: Hair Loss: Causes, Treatments, and Prevention
110 A World-First By A Turkish Physician
Motion-Preserving Surgical Technique for Adolescent Kyphosis: Tethering / Band Tensioning
118 Al-Ahli Hospital Qatar: Uterine Prolapse Treatment
52 Meri Istiroti, Liv Hospital Group Coordinator
70 Dr. Rafif Tayara, Pediatric Dentist & Oral Health Speaker
80 Dr. Matteo Vigo, Plastic surgeon, Medical Director at the Amwaj Polyclinic Dubai
100 Dr. Lyor Hanan, Plastic and Reconstructive Surgeon at Beauté Concept by CSHP in Dubai
104 Mr. Hassan Elsokkary, CEO of eHealth: Pioneering the Future of Modern Healthcare Facilities
108 Dr. Mohamad Mansour, Director of Non-Invasive Cardiology Department at Clemenceau Medical Center, Beirut
94 Beckman Coulter's New DxC 500i Analyzer: Revolutionizing Laboratory Efficiency
62 Saudi Arabia's Healthcare Sector in Vision 2030:
116 Revolutionizing Psychiatry
120 The Smart Pharmacy
124 Unlocking the Future: Genomics and Precision Medicine
Take Center Stage in the GCC
66 Introducing Precision Health at IGH Clinic
76 Clemenceau Medical Center: Pioneering Advanced Healthcare in the Middle East and Beyond
88 Memorial Hospitals Group
98 Theranostics treatments for cancer underway at UCLA Health
112 Cinfa: Improving the quality of healthcare solutions for patients
114 ‘A one-and-done treatment’: UChicago Medicine among the first in the U.S. to use TIL therapy for advanced skin cancer
First-of-its-kind international certification recognizes sustainability impact of healthcare organizations
The healthcare sector contributes to nearly 5.2% of global greenhouse gas emissions while facing increasing health impacts from climate change, according to a 2022 report of the Lancet Countdown. As healthcare organizations strive to decarbonize and become more resilient, Joint Commission International (JCI), in collaboration with the International Hospital Federation’s Geneva Sustainability Centre (GSC), announced a new international Healthcare Sustainability Certification (HSC). The HSC program, effective 1 January 2025, is available to healthcare organizations outside the United States and its territories that are
accelerating their sustainable practices and seeking formal recognition. For the first time, this certification is available to any institution whether JCI accredited or not. The certification provides a framework to help healthcare leaders initiate sustainability priorities and develop a formal governance structure to gain successful results.
“Together, Joint Commission International and the International Hospital Federation are supporting and celebrating healthcare organizations around the world that are leading the way in sustainable healthcare,” said
U.S. HOSPITALS AND CRITICAL ACCESS HOSPITALS MAY APPLY FOR THE JOINT COMMISSION’S SUSTAINABLE HEALTHCARE CERTIFICATION, WHICH HAS BEEN AVAILABLE SINCE JAN. 1, 2024
Jonathan B. Perlin, MD, PhD, President and Chief Executive Officer, The Joint Commission and Joint Commission International. “These organizations inspire others to follow in their footsteps so that healthcare can become more resilient, able to serve patients and communities during extreme weather events, and provide meaningful and lasting benefits for the health of the planet.”
The certification process includes GSC’s Sustainability Accelerator Tool (SAT), a comprehensive digital platform that allows healthcare organizations to assess their performance with core indicators and benchmark against comparable healthcare organizations worldwide. The SAT also provides insights on how healthcare organizations can enhance their sustainability strategies and improve processes, as well as offers a framework to guide essential decision-making dialogue with executives.
The SAT assesses sustainability maturity across three essential domains:
• Environmental impact
• Health, equity, and well-being
• Leadership and governance
“There is no more doubt that the climate crisis is a health crisis. The healthcare sector has many opportunities to contribute to a more sustainable and resilient future, while ensuring safe quality care,” explained Ronald Lavater, CEO of the International Hospital Federation. “The International Hospital Federation and Joint Commission International worked together to develop the JCI-GSC Healthcare Sustainability Certification as part of our mission to support hospitals to become leaders for sustainability in their communities.”
In addition to completion of the SAT assessment, healthcare organizations need to meet the certification’s requirements which are closely connected to the SAT’s core indicators. The requirements offer an advanced framework that expands on the Global Health Impact chapter from JCI’s 8th edition Accreditation Standards for Hospitals and Academic Medical
Centers. These requirements enhance the foundational goals established in the 8th edition by incorporating advanced metrics for carbon emissions, resource management, leadership involvement, employee engagement and climate resiliency. Sustainable practices can lead to improved health outcomes for patients, staff and communities. Through the certification, healthcare organizations contribute to broader environmental conservation and preservation goals, as well as achieve operational efficiencies that result in cost reductions. Healthcare organizations that achieve the certification also receive JCI’s Gold Seal of Approval®, a universally recognized symbol of quality and patient safety, and build brand recognition as responsible care leaders in an increasingly environmentally conscious world.
Any healthcare organization outside of the United States that meets eligibility requirements may now apply for HSC with certification reviews to begin on 1 January 2025. Members of the International Hospital Federation qualify for a 10% discount on the certification.
U.S. hospitals and critical access hospitals may apply for The Joint Commission’s Sustainable Healthcare Certification, which has been available since Jan. 1, 2024.
THE CERTIFICATION PROCESS INCLUDES GSC’S SUSTAINABILITY ACCELERATOR TOOL (SAT), A COMPREHENSIVE DIGITAL PLATFORM THAT ALLOWS HEALTHCARE ORGANIZATIONS TO ASSESS THEIR PERFORMANCE WITH CORE INDICATORS AND BENCHMARK AGAINST COMPARABLE HEALTHCARE ORGANIZATIONS WORLDWIDE
ADHDS, the operator of Malaffi, takes an International leap with a groundbreaking partnership with Presight to drive digital healthcare transformation in Jordan
Presight, the region’s leading big data analytics company powered by generative artificial intelligence (AI) has been awarded a multi-million-dollar contract by Jordan’s Ministry of Digital Economy and Entrepreneurship (MODEE) that will set the pace of digital transformation in the country’s healthcare sector.
The contract will see Presight leverage M42’s Abu Dhabi Health Data Services (ADHDS) expertise gained from their successful healthcare digital transformation projects in Abu Dhabi. This will serve as a blueprint to accelerate the adoption of innovative technologies and data-driven strategies aimed at improving healthcare outcomes for Jordanian citizens. Additionally, utilizing its big data analytics capabilities, Presight will implement state-of-theart solutions to derive actionable data insights.
Key elements of the contract include, among other groundbreaking projects, the delivery of a comprehensive public sector digital healthcare assessment and roadmap including strategic PMO, health information exchange strategy and business case and establishment of a virtual hospital “Command Center” that provides tele-ICU, tele-radiology and tele-dialysis “nextgeneration” services to peripheral hospitals. Through this initiative, the MODEE aims to capture the vast majority of clinical encounters on this journey towards a digitally transformed healthcare landscape. This is expected to result in resource efficiencies, enhancement of the quality of care, streamlining of healthcare costs and greater access to critical medical services across the country.
Work has already commenced with an inaugural meeting between all stakeholders held in Jordan in the presence of H.E. Ahmad Hanandeh, Jordan’s Minister of Digital Economy and Entrepreneurship, and H.E. Dr. Firas AlHawari, Jordan’s Minister of Health.
Commenting on the initiative, H.E. Dr. Firas Al-Hawari said: “Digital transformation in the healthcare sector is no longer just an option but
an urgent necessity for achieving national goals in providing comprehensive care. Initiatives such as these are crucial for advancing the healthcare sector and keeping it aligned with global developments. With this initiative, we shall develop a comprehensive strategy to establish a roadmap for future digital healthcare initiatives, that will be of immense benefit to the people of Jordan.
Dr. Adel Alsharji, COO of Presight, stated: ”AI-driven technologies are revolutionizing healthcare and reshaping our approach to health and wellness. This contract with Jordan’s Ministry of Digital Economy and Entrepreneurship reflects our commitment to using AI-powered analytics responsibly to create societal value and our dedication to ethical practices and patient data security. Our goal is to advance a healthier future in Jordan and beyond by integrating AI technologies with human expertise.”
Commenting on the importance of the agreement, Kareem Shahin, Chief Executive Officer, M42’s Abu Dhabi Health Data Services, said: “Abu Dhabi exemplifies how data and advanced technology can transform healthcare management and delivery. This partnership marks a crucial step in shaping the future of Jordan’s healthcare sector. We are eager to apply our experience from working with Abu Dhabi’s Department of Health to contribute to Jordan’s transformation, making healthcare more accessible, efficient, and responsive to all citizens’ needs.”
Featuring a large gantry aperture, the NewTom 7G is the most advanced CBCT device on the market.
From in-depth detail to the big picture.
As of today NewTom 7G incorporates the Dual Energy (DE) system, elevating performance to new heights and revolutionising the way your practice operates.
Dual Energy: patented NewTom technology
The result of a continuous quest for patient well-being and ever-greater diagnostic precision, Dual Energy uses two different radiant energies to identify any pathologies with greater clarity and precision.
Virtual Monochromatic Images
Dual Energy technology mitigates beam-hardening artifacts. What’s more, being able to reconstruct monochromatic virtual images at different keVs improves soft tissue imaging quality and reduces metal artifacts. Lastly, Dual Energy CBCT provides a basis for tissue characterisation.
Colour-coded images
NewTom Dual Energy software enables users to perform semiautomatic tissue segmentation and apply colour codes, streamlining the differentiation of materials within the scanned area. This allows rapid and straightforward detection of potential pathologies.
Blended image
The new features enable weighted blending of high- and low-energy imaging. The resulting images combine the low noise, typical of highenergy acquisition, with the high contrast resolution of the low-energy image set.
King Faisal Specialist Hospital & Research Centre (KFSHRC) is at the forefront of the healthcare AI revolution. Since 2019, the hospital's dedicated AI center has been developing innovative applications that are transforming patient care.
The center has made significant strides in diagnostics and treatment, developing over 20 AI applications. These applications leverage deep learning to analyze medical images with high accuracy, enabling more precise and faster disease diagnosis. AI has also facilitated personalized treatment plans for patients based on comprehensive health data, resulting in improved outcomes. Recently, the center unveiled its latest advancements in generative AI, developed entirely in Saudi Arabia. These innovations are expected to solidify the hospital's position as a global leader in smart healthcare.
At the Global AI Summit (GAIN), KFSHRC showcased its cutting-edge generative AI, demonstrating its commitment to becoming a more intelligent hospital. These AI models, once rigorously tested, will be fully integrated into hospital operations, enhancing efficiency and accuracy. The hospital's AI center has significantly improved operational efficiency. By automating tasks like summarizing scientific literature and monitoring patient journeys, AI has reduced bed wait times from 32 hours to 6 hours and shortened emergency department wait times by 14%. Additionally, 90% of patients now receive pharmacy and laboratory services
within 15 minutes. For its pioneering work in AI, KFSHRC has received numerous accolades, including the 2022 AI Leadership Award from the International AI and Cloud Computing Conference and Exhibition. The hospital's "Anfal" system, an AI-powered platform for predicting patient satisfaction, won the 2024 International Business Excellence Award (IBXA) for best use of customer insights.
Recognized as a global leader in specialized healthcare, King Faisal Specialist Hospital & Research Centre was ranked 20th in the world's top healthcare institutions in 2023 by Brand Finance, securing the top spot in the Middle East and Africa.
AT THE GLOBAL AI SUMMIT (GAIN), KFSHRC SHOWCASED ITS CUTTING-EDGE GENERATIVE AI, DEMONSTRATING ITS COMMITMENT TO BECOMING A MORE INTELLIGENT HOSPITAL . THESE AI MODELS, ONCE RIGOROUSLY TESTED, WILL BE FULLY INTEGRATED INTO HOSPITAL OPERATIONS, ENHANCING EFFICIENCY AND ACCURACY.
A n exc e ptio n al g ro u p devote d to
Cedars-Sinai is proud to be recognized eight years in a row on the “Best Hospitals” Honor Roll and ranked among the top fi ve in the U.S. in six specialties by U.S. News & World Report . As a global leader in healthcare, we offer a full range of services to patients from around the world. Whether we’re providing clinical services in your region, via video visits or at our main campus in Los Angeles, our mission remains unchanged: to give patients access to excellence in healthcare— wherever they may be.
• Cancer
11 specialties ranked among the best in the U.S.
• Cardiology, Heart & Vascular Surgery
• Diabetes & Endocrinology
• Ear, Nose & Throat
• Neurology & Neurosurgery
• Obstetrics & Gynecology
• Orthopedics
• Pulmonology & Lung Surgery
• Gastroenterology & GI Surgery
• Geriatrics
• Urology
Learn more: cedars-sinai.org/international | cedars-sinai.org/globalcollaborations
Scan the QR code to follow us on LinkedIn.
Patient comfort and well-being are getting more important within hospital care. The design of the room and the entire design concept can play a significant role in recovery.
The Essenza 300 bed enables the integration of advanced medical beds into a unique hospital room concept due to SMART LINK technology. Thanks to SMART LINK you create the original design of bed ends and side rails.
Thanks to the unique technologies in LINET production can adapt the bed to your needs. We are ready to integrate colors and graphic motifs such as logos, photos, or other graphic elements.
Essenza 300 is a top-quality, smart hospital bed available as a universal low-height bed or Essenza 300 LT with bed-framed lateral tilt.
Jitka Stranska Managing Director of LINET MEA
“The fusion of hospital care and hotel services is increasingly evident. Prestigious hospitals not only pay attention to high-level medical standards but also to other aspects of hospitality, including, among others, top-quality interior design. We are delighted that our beds are once again bringing a new element: personalized room customization. Thanks to special technology, our new Essenza 300 bed offers a completely individual design to match the room concept or create pleasant healing environment.”
T he Uni ve r si t y o f
t o t he F o r ef r on t
Where some of the greatest advances in medicine are hard at work for you. The University of Chicago Medicine pioneers the kind of research that’s changing lives. It is home to the most advanced medical technology, and physicians who work at the forefront of their fields.
It is our mission to bring the forefront of medicine to the world through personalized international patient services and tailored global advisory and education programs.
Clinical Centers of Excellence
» Comprehensive Cancer Center
» Transplant Institute
» Heart & Vascular Center
» Neuroscience Center
» Digestive Diseases Center
» Orthopaedic Surgery
» Obstetrics & Gynecology
» Pediatrics
For more information, visit UChicagoMedicine.org/global
100 Nobel L aureates, including 12 in Physiology or M e dicin e
Magnet Recognition for E xcelle nce in N ursing & Patie nt C are
O n e of only 15 acute - c are facilities nationwide to receive “A” grade in patie nt safet y f rom Leapf rog G roup for 25 consecu tive period s as of M ay 202 4
Ranked nationally in multiple adult and childre n’s specialties by U S N ews & World R epor t
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has published a comprehensive Healthcare Workforce Bioethics Guidelines in a pioneering step towards ensuring standardised ethical practices in Abu Dhabi’s dynamic healthcare sector.
Built on best practices and in consultation with subject matter experts, bioethics is the study and practice of ethical implications and applications related to health and technology, including those emerging from advances in biology, medicine, and health-related sciences.
The new set of guidelines, which address the increasingly complicated ethical issues in the sector as it continues to grow and advance, were developed in line with findings from a series of workshops with more than 120 global experts and leaders in bioethics and in consultation with local and international experts.
The development of the guidelines aim to strengthen compliance with existing bioethical laws and is a testament to DoH’s unwavering commitment to enhancing healthcare quality while positioning Abu Dhabi as a global leader in healthcare ethics and innovation
H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said, “Abu Dhabi’s healthcare sector continues to grow at an exponential rate spearheaded by innovation. Our ethical standards must therefore reflect the dynamics of the market while considering the cultural values of the community we serve. The Healthcare Workforce Bioethics Guidelines address the ethical implications of technological advancements in healthcare, providing a framework for the responsible adoption of innovations such as artificial intelligence, genomics, and personalised medicine. This is crucial in maintaining the integrity of the healthcare system while embracing cutting-edge technologies that enhance patient care and
outcomes. Moreover, the guidelines enhance preparedness for atypical events, ensuring that the diverse healthcare sector is better equipped to handle emergencies and crises effectively while adhering to rigorous ethical standards. This proactive approach not only safeguards the health and well-being of the community but also positions Abu Dhabi as a resilient and forward-thinking healthcare leader on the global stage”.
The guidelines were developed in partnership with the UAE Ministry of Health and Prevention (MOHAP) and Sharjah Health Authority (SHA) and are recognised as a national reference for ethical considerations. Building on the existing Code of Ethics and Professional Conduct for Health Professionals (‘Code’) issued by the federal Ministry of Health and Prevention (‘MOHAP’) in 2017, The Healthcare Workforce Bioethics Guidelines aim to raise the profile of the local healthcare sector on a global scale in line with national efforts to transition to a knowledge-based economy.
Also commenting on the newly published guidelines, Dr. Rashed Obaid Al Suwaidi, Executive Director of Healthcare Workforce Planning Sector at DoH, said: “The establishment of a national guideline for bioethics is more relevant now than ever as the healthcare sector in the UAE continues to attract top talent from around the world. By establishing a uniform set of ethical standards, the guidelines ensure that healthcare professionals across the emirate adhere to the highest ethical principles, fostering trust and confidence among patients and the community. By raising awareness of patient rights and promoting ethical practices, the guidelines contribute to a more informed and engaged community, empowering individuals to make better healthcare decisions and fostering a culture of transparency and accountability”.
THE HEALTHCARE WORKFORCE BIOETHICS GUIDELINES ADDRESS THE ETHICAL IMPLICATIONS OF TECHNOLOGICAL ADVANCEMENTS IN HEALTHCARE, PROVIDING A FRAMEWORK FOR THE RESPONSIBLE ADOPTION OF INNOVATIONS SUCH AS ARTIFICIAL INTELLIGENCE, GENOMICS, AND PERSONALIZED MEDICINE.
Cuts time to access critical patient information in half and significantly reduces time spent on administrative tasks
King’s College Hospital London, in Dubai (KCH Dubai), has become one of the first UAE-based health systems to migrate its Oracle Health Electronic Health Record (EHR) to Oracle Cloud Infrastructure (OCI).
With OCI, KCH Dubai is improving the security, performance, and usability of the EHR resulting in a better experience for its patients and providers. KCH Dubai is now providing more than 1,000 concurrent users across its facilities with access to more efficient workflows and improved system performance. Moving to the cloud has also provided the hospital network with the scalable foundation it needs to simplify integrations and meet its goal of innovating in critical areas such as population health.
Following its rapid migration to OCI, KCH Dubai is seeing positive results across the hospital including cutting the time it takes to access patient information by 50%, a 20% reduction in reviewing each patient’s medical chart, and a 25% overall reduction in time spent in the EHR due to faster screen loads and transaction response times. The overall increased speed and responsiveness of the system is helping to streamline processes so clinicians can complete tasks more quickly and free up more time to spend with patients.
The performance gains also enable more comprehensive and real-time updates to the patient record, which strengthens communication and care coordination across all caregivers to enhance patient care.
“With Oracle Health, we’ve seen substantial improvements in our clinical processes, including an increase in the system’s speed and responsiveness and a noticeable deduction in the time spent reviewing patient charts across various specialties,” said Kimberly Pierce, Chief Executive Officer, KCH Dubai. “Oracle’s cloud
offering has the technological infrastructure we need to fully embrace future advancements in areas such as generative AI that will benefit our patients and how we deliver care while better supporting our practitioners.”
With OCI, KCH Dubai can also now rely on Oracle’s real-time threat detection and monitoring, autonomous systems, and team of experts to help protect its networks against the constantly changing cybercrime landscape. In addition, OCI will support scalability of healthcare technology as KCH Dubai expands with new facilities and specialties, ultimately growing its overall operation and capacity to care for its community.
“The combined power of OCI and our EHR is enabling KCH Dubai physicians to be more productive, waste less time in medical records, and refocus more time on patient care,” said Seema Verma, Executive Vice President and General Manager, Oracle Health and Life Sciences. “Moreover, they have the comprehensive platform to continually be able to plug-in the technologies they need to solve their toughest challenges and be more adaptable, predictive, and responsive to evolving healthcare needs.”
WITH OCI, KCH DUBAI CAN ALSO NOW RELY ON ORACLE’S REAL-TIME THREAT DETECTION AND MONITORING, AUTONOMOUS SYSTEMS, AND TEAM OF EXPERTS TO HELP PROTECT ITS NETWORKS AGAINST THE CONSTANTLY CHANGING CYBERCRIME LANDSCAPE.
Our experts get to know you, then tailor treatments to help fit your needs—which could include radiation, surgery, chemotherapy, immunotherapy, cellular therapy, genetic counseling, or a customized lifestyle management plan. In collaboration with Baylor College of Medicine, we’re equipped to pave the way for even more revolutionary discoveries and groundbreaking approaches to cancer prevention, diagnosis, and treatment.
Learn more about the NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine at stlukeshealth.org/bslmcinternational
Mubadala Health Dubai, part of the M42 Group, provides specialized treatment for headaches, enabling sufferers to regain control of their lives. Utilizing the latest research, innovative treatments and a holistic approach, Mubadala Health Dubai’s newly launched Headache Clinic aims to improve the quality of life for patients with headaches and chronic migraines. Recently, it helped treat a 75-year-old patient who risked possible blindness due to a misdiagnosed condition. The patient had been experiencing uncontrollable headaches for the past few months and had previously been misdiagnosed with migraines. Due to the persistence of these headaches, the patient was referred to Mubadala Health Dubai, where a correct diagnosis of temporal arteritis was made by Dr. Mohammad Aghil Ghatali, Consultant Neurologist. Temporal arteritis is an inflammation of the medium-sized vessels of the temporal artery. This condition commonly causes severe, localized headaches typically felt in the temples.
Other symptoms may include scalp tenderness, jaw pain while chewing and visual disturbances. Notably, temporal arteritis can lead to visual loss, which poses a significant risk of blindness if left untreated. Inflammation of the temporal arteries can affect the arteries that supply blood to the eyes, leading to reduced blood flow and potentially causing sudden vision loss. This condition, known as anterior ischemic optic neuropathy, can result in permanent blindness if not treated quickly. It’s crucial to start treatment with corticosteroids as soon as possible to reduce inflammation and prevent serious complications like blindness.
Dr. Mohammad Aghil Ghatali said: “I saw the patient in the clinic’s corridor rocking and pacing due to his pain. Immediate treatment with high-dose prednisone not only relieved the patient’s headache but also prevented potential blindness. This success story highlights the importance of accurate diagnosis and timely intervention.”
The patient commented: “It was due to Dr. Ghatali’s extensive experience that my condition was identified and treated. I am finally free of my debilitating symptoms, and I was shocked to learn that I could have gone blind if my condition hadn’t been caught in time.”
Giant cell arteritis is a type of vasculitis, which means inflammation of the blood vessels. It is an autoimmune disease, where the immune system mistakenly attacks the body’s own tissues. In this case, the immune system attacks the blood vessels in the head. Both rheumatologists, who specialize in autoimmune diseases, and neurologists, who focus on the nervous system, work together to manage conditions like giant cell arteritis and other similar diseases.
As part of the clinic’s multidisciplinary approach, the patient was then referred to Dr. Nathalie Chalhoub, Consultant Rheumatologist at Mubadala Health Dubai. Giant cell arteritis, also known as temporal arteritis, is a type of vasculitis, characterized by inflammation of the blood vessels. It is an autoimmune disease in which the immune system mistakenly attacks the body’s own tissues, specifically targeting the blood vessels in the head. Both rheumatologists, who specialize in autoimmune diseases, and neurologists, who focus on the nervous system, collaborate to manage conditions such as giant cell arteritis and other similar diseases.
CONSULTANT NEUROLOGIST SPOTS PREVIOUSLY UNDETECTED SIGNS IN 75-YEAR-OLD WHO WAS MISTAKENLY DIAGNOSED WITH MIGRAINES.
In its continued efforts to enhance government service efficiency and improve customer experience, Emirates Health Services has announced significant achievements in implementing the UAE’s Zero Government Bureaucracy Program. This initiative aims to simplify and streamline government procedures, thereby increasing efficiency and strengthening the UAE's leadership and global competitiveness.
EHS aims to implement 60 streamlining operations across its services to eliminate bureaucratic hurdles that impede the efficient and timely delivery of healthcare. These efforts are projected to save over 9 million workflow steps, reduce 1 million visits to service centers, and cut down on more than 900,000 paper documents. Additionally, the time required to access services has been reduced by 60%, resulting in savings of over 80 million minutes for customers and more than 60 million dirhams in service costs.
H.E. Dr. Yousif Mohammed Al Serkal, Director General of Emirates Health Services (EHS), emphasized that EHS remains committed to adopting the best global practices and innovative solutions to enhance the efficiency of the UAE’s healthcare system, in alignment
with the objectives of the Zero Government Bureaucracy Program. He highlighted that these efforts not only improve the customer experience but also support the nation's strategy to achieve the "We the UAE 2031" vision, ultimately contributing to the UAE Centennial Plan 2071.
EHS’s zero-bureaucracy initiatives include various projects in multiple areas, including simplifying admission procedures for healthcare facilities, streamlining patient journeys for obtaining medications and medical supplies, facilitating medical appointment bookings, and expanding telemedicine services to a broader audience. Other projects include launching a preventive dental screening program for school students and reducing the time required for diagnostic breast imaging services.
Ongoing projects at EHS focus on accelerating medical fitness tests for residence visas, university students, and new employees, launching virtual clinics, simplifying procedures for obtaining birth and death certificates, and enhancing processes for issuing and renewing health cards for People of Determination. These initiatives aim to make healthcare services more accessible and efficient. EHS is intensifying its efforts by establishing a strategic plan aimed at implementing the Zero Government Bureaucracy Program to achieve long-term results. It is also committed to regularly evaluating performance to ensure the sustainability of improvements and enhance efficiency, quality, and governmental flexibility, thereby boosting the UAE's global competitiveness.
EHS’S ZEROBUREAUCRACY
INITIATIVES INCLUDE VARIOUS PROJECTS IN MULTIPLE AREAS, INCLUDING SIMPLIFYING ADMISSION PROCEDURES FOR HEALTHCARE FACILITIES, STREAMLINING PATIENT JOURNEYS FOR OBTAINING MEDICATIONS AND MEDICAL SUPPLIES, FACILITATING MEDICAL APPOINTMENT BOOKINGS, AND EXPANDING TELEMEDICINE SERVICES TO A BROADER AUDIENCE.
Taking a breath might seem simple, but for some, lung function presents a complex puzzle: hidden breathing problems can be a concern for anyone. This is why early detection is key, and that’s where the Medikro Spirometer comes in. This valuable tool, especially the Medikro Pro version, offers a clear picture of lung function, making it a game-changer for healthcare professionals. Forget traditional spirometry’s limitations. The Medikro Pro offers cutting-edge technology, delivering highly accurate lung function measurements. This empowers healthcare professionals to confidently diagnose and monitor respiratory issues like asthma, COPD, and restrictive lung disease - leading to personalized treatment plans and improved patient outcomes.
All of this while prioritizing ease of use : its disposable flow sensors eliminate the need for sterilization, minimizing the time spent and reducing the risk of contamination, as well as its easy connection to PC software featuring an intuitive interface and clear result visualization for quick and efficient analysis. All that being said, Medikro Spirometer, particularly the Medikro Pro model, offers a valuable tool for both healthcare professionals and patients. With its precision, efficiency, and patient-centric design, it paves the way for early detection, accurate diagnosis, and ultimately, a clearer path to easier breathing.
Cleveland Clinic Abu Dhabi, part of the M42 group, in collaboration with NYU Abu Dhabi, leveraged a cutting-edge three-dimensional (3D) printing technology to print a 3D model of the heart and plan a complex surgical intervention on a 41-year-old patient, Mian Mohamed Shabbie, with rare cardiovascular anomaly.
The technology developed by NYU Abu Dhabi’s Core Technology Platform can be used in various fields such as cardiovascular and neurological cases. The process involves three stages; 3D image reconstruction, a procedure that involves creating a three-dimensional model from raw diagnostic imaging data to provide a foundational digital framework of the patient's anatomy; 3D slicing, which allows for a more detailed analysis of the individual structures and organs in greater detail and; 3D printing, which involves building a physical replica of the patient's anatomy that the surgeon can hold, examine, and use for pre-surgical planning and simulation. This technology is instrumental in understanding the unique challenges of each case and allows for a more precise and tailored surgical approach with the highest accuracy and minimum risks.
When Shabbie was referred to Cleveland Clinic Abu Dhabi in a critical condition, he was presented with complications stemming from a birth defect of the aorta, the main blood vessel that carries blood away from the heart. In Shabbie’s case, his aorta – which normally has a left-sided arch after exiting the heart - had a right-sided arch with a giant aneurysm. The aneurysm itself was of a rare kind, known as Kommerell's diverticulum, which has one of the main branches of the aorta, with a bulge at the site of its origin.
Explaining the case, Dr. Houssam Younes, Department Chair for Vascular Surgery within
the Heart, Vascular & Thoracic Institute at Cleveland Clinic Abu Dhabi, said, "Kommerell's diverticulum is a rare cardiovascular abnormality, even more so when combined with a right-sided aortic arch, as seen in only 0.03% of people worldwide. Due to its asymptomatic nature or presentation with symptoms commonly associated with other conditions, these congenital deformities are infrequently detected, calling for a high level of physician and technological expertise during surgical interventions."
Dr. Yazan Aljabery, Cardiac Surgeon within the Heart, Vascular & Thoracic Institute at Cleveland Clinic Abu Dhabi, explained, "Correcting a case of Kommerell's diverticulum when the aorta arches left, as is typical, is relatively straightforward because the deformity is accessible and visible. However, when the vessel arches right, as in this case, the defect is obscured by other large vessels, making surgical interventions particularly challenging. Using a 3D-printed model in such cases enhances the safety of the procedure and allows for more precise and tailored surgery."
Cleveland Clinic Abu Dhabi has been designated by the Department of Health – Abu Dhabi (DoH) as a Centre of Excellence for Adult Cardiac Surgery, recognizing its comprehensive range of integrated cardiac surgery and structural heart disease interventions provided by a team of some of the world's most reputable cardiovascular experts.
Ongoing research by the multidisciplinary teams of experts at the hospital aims to showcase that the technology is not limited to cardiovascular or neurological applications but is also valuable in other medical fields where complex anatomical structures are involved.
With a vast and diverse portfolio, Pharmatrade offers over 5000 high-quality products. These encompass a wide array of medical and pharmaceutical supplies, catering to various healthcare needs. Pharmatrade's product range is carefully curated to meet the requirements of both the Government and Private sectors in the UAE.
46 Years of Exellence
30+ Multinational Companies
5,000+ Products in Portfolio
In this exclusive interview, Mrs. Meri İstiroti, the Group Coordinator of Liv Hospital, shares her insights into the innovative services that set Liv Hospital apart in the ever-evolving world of healthcare. Liv Hospital Group is known for its cuttingedge approaches and has established itself as a leader in both local and international healthcare. Mrs. Istiroti examines the distinctive approach and services that define Liv Hospital, from personalized care to integrating advanced technologies. She also discusses the Hospital Group's prominent role in international healthcare. Additionally, she offers a forward-thinking perspective on Healthcare 5.0, a concept that is revolutionizing patient care and reshaping the future of the medical industry.
We will discuss the future of health and trends in detail, but first of all, can we get to know you a little bit?
I have been working in the healthcare industry for 34 years. After graduating from Boğaziçi University, Department of Psychology, I completed my Master's degree in Health Management at Istanbul University and Bahçeşehir University. I have worked in many healthcare organizations, such as International Hospital, American Hospital, and Yaşamkent, a subsidiary of Bayındır Holding. I took part in the opening of many new hospitals in Acıbadem Health Group. When I left the Group as Assistant General Manager, the organization had 9 hospitals and 24 branches, a Health Insurance Company, a University, a project company that carried out turnkey hospital works, and many group companies focused on health. Since 2012, as Liv Hospital Group Coordinator, I took part in the establishment of the brand and the processes of a new health institution. Liv Hospital continues its journey that started in 2013 with eight hospitals in both Türkiye and other countries.
Could you tell us about the innovative healthcare services offered by Liv Hospital Group?
At Liv Hospital, we always aim to offer innovative healthcare solutions. Internationally, we provide treatment for many genetic and neurological diseases with Stem Cell and Regenerative therapies. Our recently developed robotic surgery, smart hospital applications, and telemedicine services reinforce our leadership in this field. The solutions we offer, especially
in the fields of robotic rehabilitation and personalized medicine, attract great interest in the international arena. We also organize continuing education programs for doctors and healthcare professionals through Liv Academy, creating a permanent network of knowledge sharing and development.
What are the general trends that stand out in the Hospital sector today?
The hospitality sector has been undergoing significant changes in recent years, and several key trends stand out. Firstly, digitalization and technology integration are one of the most noticeable trends. Innovations such as electronic health records, telemedicine, artificial intelligence-assisted diagnosis, and treatment methods are improving the patient experience while increasing the operational efficiency of hospitals. In addition, patient-centered care is becoming increasingly important. Patients are now demanding not only treatment but also a comprehensive healthcare experience. Therefore, hospitals are focusing on providing personalized services to improve patient satisfaction. Another important trend is sustainability and green hospital concepts.
Building environmentally sensitive, energyefficient structures and adopting sustainable practices ensure that hospitals benefit both environmentally and economically. In the postpandemic era, resilient and emergency-prepared health infrastructures have also become important. Finally, driven by globalization, hospitals are expanding their services for international patients and investing to become more competitive in this area.
What are the features that make Liv Hospital different from other hospitals?
At Liv Hospital, many advanced applications are performed by the latest technology and experienced specialist physicians. With the personalized “Regenerative Medicine Stem Cell Production and Application Center” established in GMP standards for the first time in a hospital in our country, all kinds of treatments ranging from cosmetic dermatology-aesthetics to orthopedics, from wounds that do not heal to burn treatment, muscle diseases in children and autism are performed.
The most complicated cancer surgeries are performed with robotic surgery infrastructure and operating room suites, hybrid operating
AT LIV HOSPITAL, OUR TEAM WORKS WITH SPECIALIZED UNITS FOR INTERNATIONAL PATIENTS AND CREATES PROFESSIONAL TEAMS THAT UNDERSTAND THE LANGUAGE AND CULTURAL NEEDS OF EACH PATIENT.
rooms that bring a new dimension to healthcare services by combining traditional surgical methods with modern technology. Not only in cancer, robotic knee and hip replacements are performed with the MAKOplasty robot. We are the AOSpine Surgery Training Center for spine treatment in many European countries such as France and Germany. Non-surgical laser treatments such as HIFU, Nanoknife, ThuLEP are performed for prostate cancer and surgery. Cosmetic Dermatology and Aesthetic Applications are handled individually with the latest technology. Since we are a hospital with a team of experts and technology in cancer, our investments in this direction continue at full speed. With MR Linac, a 4-dimensional realtime radiotherapy investment, we have a truly groundbreaking technology in cancer.
The “Heart Health Team,” consisting of important academicians in cardiology and cardiovascular surgery who are experienced in cardiovascular diseases, decides on the most appropriate treatment for every age group, from newborn to adult.
The Pediatric Clinic offers a child-specific approach and comprehensive treatment options with specialists in 19 sub-branches. Special approaches to rare and complex diseases, innovative treatment practices, child and familyfriendly spaces, family support centers, and child life programs are offered.
How do you evaluate Liv Hospital Group's position in the international healthcare market?
As the premium brand of Türkiye's largest hospital chain, Liv Hospital Group is in a very strong position in the international healthcare market. Our success is based on our mission to deliver high-quality healthcare, our innovative approaches, and our global connections. Our hospitals in Türkiye have become centers of choice not only for local patients but also for international patients. We are also an important actor in the international health tourism market. The special services and personalized treatment options we offer to our patients from the Middle East, Europe, Africa and the Commonwealth of Independent States (CIS)
make Liv Hospital stand out in this market.
In addition, thanks to our global connections, we have the ability to rapidly implement the latest medical technologies and treatment modalities. This makes us a recognized and trusted healthcare provider in the international arena. As Liv Hospital Group, we not only have a strong position in existing markets, but we are also constantly developing strategies to expand into new markets. Our goal is to consolidate our leadership in international healthcare and provide world-class healthcare services to more patients.
What is Cross-Border Healthcare and what role does Liv Hospital play in this field?
Cross-border healthcare refers to when a patient receives medical treatment in another country outside their country of residence. These services involve patients traveling to another country for different reasons, for example, for lower costs, shorter waiting times or access to treatments that require advanced technology and expertise.
At Liv Hospital, our team works with specialized units for international patients and creates professional teams that understand the language and cultural needs of each patient. To make our patients feel at home during their treatment, we offer a comprehensive support service, which provides them not only with medical care, but also with a complete healthcare experience from start to finish.
We also offer services specifically designed to facilitate our patients' travel, accommodation and post-treatment processes. This is part of the versatile and personalized care that Liv Hospital offers to its patients. As Liv Hospital, we continue to offer world-class treatment options to our patients by maintaining our leadership in cross-border healthcare services.
Would you like to evaluate the situation of health tourism in Türkiye?
AS THE PREMIUM BRAND OF TÜRKIYE'S LARGEST HOSPITAL CHAIN, LIV HOSPITAL GROUP IS IN A VERY STRONG POSITION IN THE INTERNATIONAL HEALTHCARE MARKET. OUR SUCCESS IS BASED ON OUR MISSION TO DELIVER HIGH-QUALITY HEALTHCARE, OUR INNOVATIVE APPROACHES, AND OUR GLOBAL CONNECTIONS. OUR HOSPITALS IN TÜRKIYE HAVE BECOME CENTERS OF CHOICE NOT ONLY FOR LOCAL PATIENTS BUT ALSO FOR INTERNATIONAL PATIENTS.
Health tourism is a huge economy that provides serious income to our country. In the 2005s, the main reason for tourists to choose our country was that they could get more affordable services. But then the reasons for preference gave way to receiving more qualified services. In other words, they started to experience good and successful medical outcomes with a better service approach in better environments. Our strongest point as a country in health tourism is our ability to provide diagnosis and treatment services by combining experienced and highly specialized physician staff with up-to-date technology.
We also have extremely successful results that demonstrate our strength in high-risk treatments. Highly professional patient services, a hospitable and comfortable hotel management approach, up-to-date technology, a very rich culture and geography in terms of tourism are among our most important reasons for preference.
What is Liv Hospital's approach to health tourism?
Liv Hospital has so far received patients from 182 countries, mainly from 35 countries. It has an overseas marketing team speaking 25 different languages. But the difference of this team is not only that they speak 25 languages, but that they are all citizens of the country they are responsible for. Thus, Liv Hospital guests do not feel lonely even if they are hundreds of kilometers away from their country. They are hosted by people who know their culture, language and country. Knowing the needs of different cultures and acting according to their sensitivities requires a different kind of attention and virtue.
Our guests from abroad become members of the Liv Hospital Family from the moment they set foot in the country until they return to the airport. Our most important reasons for preference are our experienced physician staff, successful implementation of challenging
GREEN HOSPITAL INITIATIVES, ENERGY EFFICIENCY PROJECTS, WATER CONSERVATION MEASURES AND COMPREHENSIVE WASTE MANAGEMENT SYSTEMS ARE AT THE FOREFRONT OF THESE STRATEGIES.
surgeries requiring specialized teamwork, highly professional patient services, a hospitable and comfortable hotel management approach, upto-date technology, and a vibrant culture and geography in terms of tourism.
The fact that Liv Hospital has accreditations such as “Center of Excellence” and “JCI” since the day it was opened, and that it is accepted as a Turquality brand by the Ministry of Economy imposes a great responsibility in the international arena.
What could be the innovations and developments that will stand out in the future in multicultural health services?
In the future, I think technology-driven innovations in multicultural healthcare will become more prominent. In particular, artificial intelligence and big data analytics will be used to better understand the cultural and personal preferences of patients and offer them specific treatment plans. This will make patients feel more understood and comfortable during the treatment process.
In addition, technologies such as virtual reality (VR) and augmented reality (AR) can be used to enrich training and patient experience in healthcare. For example, VR trainings that simulate different cultural scenarios can help health professionals become more aware and sensitive about this issue.
Finally, with the increase in global health tourism, I foresee that cultural collaborations between hospitals will also increase. This will ensure that international patients feel safe and respected at every stage of their treatment process. As Liv Hospital Group, we closely follow these innovations and are committed to implementing developments in this field to maintain leadership in multicultural healthcare.
You have received the Best Digital Health Innovation Award in Europe in Rotterdam. What do you think made this project successful?
Receiving Europe's Best Digital Health Innovation Award in Rotterdam was a great honor and a source of pride for us as Liv Hospital. There are several important factors
behind this success among many of Europe's leading hospitals participating. First and foremost, our commitment to innovation and our investments in digital health solutions were key to the success of this project. We see digital transformation in healthcare not just as a trend, but as a necessity to provide the best service to our patients.
For the first time, a digital platform with leading technology in the field of telehealth was put into service at Liv Hospital in cooperation with Türk Telekom and Healthverse PanoramicWEB.
Thanks to the Healthverse PanoramicWEB platform, patients can visit the hospital in 360 degrees under the guidance of a patient counselor from anywhere in the world, meet with their doctor and get information about the treatment to be performed. This, in turn, positively affects patient satisfaction and treatment results.
In Healthverse PanoramicWEB, which brings patient counselors, doctors and patients together online in a digital environment, healthcare professionals can fulfill their duties by being digitally cloned into the hospital thanks to the software, even if they are not in the hospital. Thanks to this project, we can bring our guests and our physicians and patient consultants together through a single link without downloading any additional application, and they can consult their physicians about all processes in the hospital from A to Z without any question marks in their minds.
We see that you value digitalization in your studies. What would you like to say about this?
Digitalization has become one of the most critical elements of modern healthcare. Technology is not only improving the operational efficiency of hospitals but also improving the patient experience and the quality of treatment. As Liv Hospital Group, we put digitalization at the center of our healthcare services because we
AS LIV HOSPITAL GROUP, WE PUT DIGITALIZATION AT THE CENTER OF OUR HEALTHCARE SERVICES BECAUSE WE BELIEVE THAT THE HEALTHCARE SYSTEM OF THE FUTURE WILL BE BUILT ON DIGITAL SOLUTIONS.
believe that the healthcare system of the future will be built on digital solutions.
Thanks to digitalization, we are able to make our health services more accessible, fast and effective. For example, electronic health records provide instant access to patient data, enabling more accurate and faster diagnoses. Our telemedicine applications are expanding access to health services by making it possible for our patients to receive remote counseling.
In addition, technologies such as artificial intelligence and data analytics help us create personalized treatment plans, which significantly improve patient results.
Our goal is to continuously improve our health services by using the most advanced technologies and to provide the best experience to our patients. This is part of our vision to become a leader not only in today's healthcare but also in tomorrow's.
How are international hospitals taking steps regarding environmental sustainability and quality standards?
Environmental sustainability is becoming an increasingly critical issue for international hospitals. Hospitals usually have a significant impact on the environment with their large energy consumption, waste production and carbon footprints. Many hospitals are developing various strategies to minimize these effects. Green hospital initiatives, energy efficiency projects, water conservation measures and comprehensive waste management systems are at the forefront of these strategies. Hospitals also achieve their sustainability goals by using environmentally friendly materials, investing in renewable energy sources, and organizing staff training to raise environmental awareness. Such measures not only fulfill environmental responsibilities but
OUR GOAL IS TO CONTINUOUSLY IMPROVE OUR HEALTH SERVICES BY USING THE MOST ADVANCED TECHNOLOGIES AND TO PROVIDE THE BEST EXPERIENCE TO OUR PATIENTS. THIS IS PART OF OUR VISION TO BECOME A LEADER NOT ONLY IN TODAY'S HEALTHCARE BUT ALSO IN TOMORROW'S
also support financial sustainability by reducing operational costs.
However, it is also crucial for hospitals to obtain internationally recognized accreditations for environmental sustainability. For example, accreditations such as JCI (Joint Commission International), Planetree, and Center of Excellence show that a hospital has high standards not only for medical excellence but also for environmental awareness and patientcentered care. Such accreditations certify hospitals' compliance with sustainability and quality standards and increase their recognition at the international level. In order to compete in the global healthcare market, hospitals have to offer safe and effective treatment at high standards. In this direction, it is important to pass through the accreditation processes in order to certify that they are in compliance with international quality standards. These processes, which are constantly being improved, strengthen the reputation of hospitals and increase their preference rates, especially in the field of health tourism.
What is Healthcare 5.0 and how is it revolutionizing healthcare?
Healthcare 5.0 refers to an era in which healthcare is reshaped by digitalization and advanced technologies. This concept has emerged with the integration of artificial intelligence, big data, the Internet of Things (IoT), robotics, and biotechnology into healthcare. Healthcare 5.0 makes healthcare services more personalized, proactive and patient-centered. In this new era, health services are not only focusing on treatment but also aiming to improve the overall quality of life of patients. The biggest difference between Healthcare 5.0 and previous healthcare services is the level of integration of technology into healthcare services. In previous periods, health services had a more reactive nature; that is, they were treated when diseases appeared. Healthcare 5.0, on the other hand, offers a more preventive and proactive approach. In this era, thanks to artificial intelligence and big data analytics, patients' health data is collected and analyzed, and potential health problems can be diagnosed early. In addition, thanks to IoT
HEALTHCARE 5.0 REFERS TO AN ERA IN WHICH HEALTHCARE IS RESHAPED BY DIGITALIZATION AND ADVANCED TECHNOLOGIES. THIS CONCEPT HAS EMERGED WITH THE INTEGRATION OF ARTIFICIAL INTELLIGENCE, BIG DATA, THE INTERNET OF THINGS (IOT), ROBOTICS, AND BIOTECHNOLOGY INTO HEALTHCARE. HEALTHCARE 5.0 MAKES HEALTHCARE SERVICES MORE PERSONALIZED, PROACTIVE AND PATIENT-CENTERED. IN THIS NEW ERA, HEALTH SERVICES ARE NOT ONLY FOCUSING ON TREATMENT BUT ALSO AIMING TO IMPROVE THE OVERALL QUALITY OF LIFE OF PATIENTS.
devices and wearable technologies, patients can monitor their health status even at home and communicate with their doctors instantly.
It significantly improves the patient experience. In this era, patients can access health services more easily and quickly. Innovations such as telemedicine and remote patient monitoring allow patients to communicate with their doctors without geographical barriers. In addition, thanks to digital health applications and platforms, patients can track their own health data and make informed health decisions based on this data. This allows patients to participate more actively in health processes. Sustainability is at the heart of the Healthcare 5.0 vision and is critical to ensuring that healthcare is effective and accessible in the long term. Therefore, the solutions developed with Healthcare 5.0 integrate sustainability principles such as energy efficiency, waste management and environmentally friendly practices.
Globalization in health has become much more important in our country, not only because of the importance given to health tourism by the private sector but also by the state, and because our country has been working primarily in this field. I hope that the participation of the Ministry of Health and the State personally in these policies will carry Türkiye further.
Our biggest goal in the future is to further consolidate our leading position in the global health tourism market. In addition, we want to increase the patient experience to the highest level by constantly updating our technological infrastructure and medical innovations.
We will also continue our efforts to explore new markets in international healthcare services and increase our share in our existing markets. As Liv Hospital Group, we will always continue to offer the most advanced healthcare solutions
OUR BIGGEST GOAL IN THE FUTURE IS TO FURTHER CONSOLIDATE OUR LEADING POSITION IN THE GLOBAL HEALTH TOURISM MARKET. IN ADDITION, WE WANT TO INCREASE THE PATIENT EXPERIENCE TO THE HIGHEST LEVEL BY CONSTANTLY UPDATING OUR TECHNOLOGICAL INFRASTRUCTURE AND MEDICAL INNOVATIONS
and provide safe, effective and people-oriented service to our patients.
How does global connectivity affect innovation in healthcare?
Healthcare is a field that transcends borders and requires global collaboration. Global connections enable the sharing of information, the transfer of best practices and the rapid adoption of innovations. In this way, standardization can be achieved between health services in different countries and patients will have the opportunity to access the best treatment methods. In addition, global networks play a vital role in rapid and effective response to global health crises such as pandemics. Strong ties between healthcare professionals, researchers and institutions from around the world accelerate knowledge exchange and facilitate the development of innovative solutions.
As Liv Hospital, we aim to provide our health
services at world standards by establishing international business associations. In this context, we actively participate in global health networks and cooperate with leading health institutions from different countries. This strategy not only helps us provide our patients with the most advanced technology and best treatment methods but also ensures the continuous development of our medical staff. Through our regular participation in international conferences, seminars and training programs, our healthcare professionals have access to the most up-to-date information and practices worldwide. Thanks to our collaborations, ranging from Boston Children's Hospital to Cleveland Clinic, we follow the best practices from around the world and implement these practices in our hospital.
AS LIV HOSPITAL, WE AIM TO PROVIDE OUR HEALTH SERVICES AT WORLD STANDARDS BY ESTABLISHING INTERNATIONAL BUSINESS ASSOCIATIONS.
Healthcare in the Kingdom of Saudi Arabia is considered a fundamental right for all citizens. The Ministry of Health is responsible for providing preventive, therapeutic, and rehabilitative healthcare services through a network of healthcare centers across the country.
The private sector also plays a pivotal role in driving the healthcare sector forward, contributing to its ongoing successes. All these efforts align with Saudi Arabia's Vision 2030 for health. The commitment to this vision has led to the development of the sector in line with future demands. Achieving this requires focusing on key principles outlined in the plan, such as innovation, public-private partnerships, and the enhancement of operational frameworks, ultimately aiming to create a leading healthcare sector that delivers medical services meeting the Kingdom’s leadership aspirations and the needs of its citizens.
It has become clear that the goal of transforming Saudi Arabia's healthcare system is to "restructure the healthcare sector in the Kingdom to be a comprehensive, efficient, and integrated system centered on the health of individuals and communities, including citizens, residents, and visitors," as stated on the official website of the Healthcare Transformation Program. This rapid progress is driven by the visionary leadership of Saudi Arabia’s young leaders, led by Crown Prince Mohammed bin Salman, who is determined to implement a public healthcare policy that meets the expectations of the country's leadership and its citizens. This endeavor is a crucial component of the broader economic reform of Saudi Arabia's systems and policies.
As part of the Saudi Vision 2030 plan, the Saudi government aims to reduce the healthcare sector's share of the national budget by fostering public-private partnerships (PPPs). The goal is to privatize 295 hospitals by 2030 to enhance the quality and efficiency of healthcare through a value-based care model.
The Saudi government has identified several issues requiring transformation, particularly concerning privatization and its implications, as well as adapting to these changes. In response, the government has launched a series of initiatives aimed at achieving universal health coverage, strengthening primary healthcare services, implementing digital health transformation, and enhancing quality and patient safety. Given the scale of this reform, attention has been focused on key institutional stakeholders, specifically healthcare providers, state-owned institutions, the insurance sector, and regulatory bodies.
Saudi Arabia's Vision 2030 emphasizes the development of the healthcare sector through privatization. Although privatization in the Kingdom has been on the rise, the public healthcare sector remains vital, according to experts, for achieving comprehensive health improvements across all population segments. With this in mind, the government must strengthen the public healthcare sector to ensure affordable, accessible, and high-quality healthcare for all.
SAUDI ARABIA'S VISION 2030 INCLUDES A COMPREHENSIVE PLAN FOR PUBLIC-PRIVATE PARTNERSHIPS, ORGANIZING AND DEVELOPING THE SECTOR THROUGH THE HEALTHCARE TRANSFORMATION PROGRAM.
Public-private partnerships (PPPs) have emerged as a crucial mechanism for fostering innovation in the global healthcare sector. This review highlights lessons learned from PPP models worldwide, emphasizing their significance and impact, and how applying these lessons could influence Saudi Arabia's healthcare sector. PPPs in healthcare innovation require collaboration between government entities, private institutions, and sometimes nonprofit organizations to address challenges such as limited resources, expertise, and infrastructure while leveraging each sector's strengths.
Saudi Arabia's Vision 2030 includes a comprehensive plan for public-private partnerships, organizing and developing the sector through the Healthcare Transformation Program. This program aims to structure and activate an integrated healthcare system across the Kingdom, focused on patient health, promoting public health, preventing diseases, and implementing a modern healthcare model.
The program also aims to provide health services and free insurance to all citizens, covering services across different geographic areas, and expanding electronic health services and digital solutions.
Vision 2030 for healthcare relies on comprehensive development across all levels, starting with infrastructure development, facilitating access to healthcare services, and extending to digital health and healthcare digitization, which reduces financial burdens and makes care accessible anywhere. Additionally, the vision aspires to provide a skilled workforce and increase life expectancy in line with international indicators.
The strategic goals of the Healthcare Transformation Program include improving access to healthcare services at the right time and place by increasing the overall capacity of hospitals (including hospital beds and medical staff) and ensuring appropriate geographic distribution. This encompasses the distance between patients and healthcare providers, timely access to necessary services, and
affordability of healthcare for individuals.
The Kingdom also seeks to improve the quality of healthcare services provided to citizens, including free insurance services, by enhancing the healthcare system's responsiveness to community needs and ensuring effective, safe, and sustainable health coverage. This strategic goal involves two main elements: public health prevention, such as community health awareness, disease prevention, and vaccinations, and managing health crises, including infectious and noncommunicable diseases, as well as responses to epidemics and natural disasters.
Saudi Arabia has made significant achievements in the healthcare sector, establishing a healthcare system that provides free services to all citizens. With increased spending on healthcare, the quality of services and outcomes has also improved.
The government has invested in healthcare infrastructure, leading to an increase in the number of hospitals and primary healthcare centers. By 2021, there were over 460 hospitals and 2,000 primary healthcare centers across the country. The Kingdom has developed programs and initiatives to improve care quality, such as the National Accreditation Program for Healthcare Organizations. Since 2021, more than 50% of the country's healthcare facilities have been accredited, with evaluations based on various criteria, including infection control, patient safety, and care quality.
Saudi Arabia has also invested in health information systems, electronic health records, and telemedicine, enhancing healthcare efficiency and making services more accessible. Prevention, public health, innovation, and sustainability are four key priorities for the Healthcare Transformation Program, which aims to expand electronic health services, digital solutions, and improve healthcare quality. The program is transforming Saudi Arabia's healthcare system into a more comprehensive and integrated one, adhering to the highest international standards in service delivery. This positions the Kingdom among the leading countries globally in leveraging technology to provide efficient and accessible healthcare services.
VISION 2030 FOR HEALTHCARE RELIES ON COMPREHENSIVE DEVELOPMENT ACROSS ALL LEVELS, STARTING WITH INFRASTRUCTURE DEVELOPMENT, FACILITATING ACCESS TO HEALTHCARE SERVICES, AND EXTENDING TO DIGITAL HEALTH AND HEALTHCARE DIGITIZATION, WHICH REDUCES FINANCIAL BURDENS AND MAKES CARE ACCESSIBLE ANYWHERE. ADDITIONALLY, THE VISION ASPIRES TO PROVIDE A SKILLED WORKFORCE AND INCREASE LIFE EXPECTANCY IN LINE WITH INTERNATIONAL INDICATORS.
Recent developments indicate a significant increase in investment in health research, digital transformation, healthcare infrastructure, workforce training, and collaboration with global health system innovators.
The Saudi government has prioritized innovation by allocating a substantial portion of the budget to research, development, and social advancement. The rising demand on the healthcare sector during the pandemic further pushed innovation forward to sustain the sector's technical quality. Research, development, and innovation are based on preventive and integrative measures to address current challenges in accessing healthcare services. Saudi government investment plans aim to expand healthcare infrastructure in alignment with Vision 2030 and beyond.
Additionally, the government plans to increase the privatization of hospitals and primary healthcare centers to support innovation and creativity. It collaborates with global health system innovators to bring the latest health technologies and expertise to the Kingdom. The Public Investment Fund attracts pharmaceutical and biotech companies to enhance medical equipment and raise the private sector's participation in the healthcare system, driving innovation and creativity forward. The benefits of innovation in Saudi Arabia's healthcare sector are numerous, including quality improvement, cost reduction, flexibility, and rapid service delivery. The Healthcare Transformation Program focuses on restructuring the sector to provide integrated medical services. Saudi health leaders are influencing others to ensure understanding and support for health innovation and creativity, such as emphasizing the importance of electronic health records in the digital transformation era. To this end, reform legislation is being issued to accelerate the adoption of innovative solutions in the digital age.
In conclusion, the aspirations and priorities for developing Saudi Arabia's healthcare system rest on four main pillars: human health, environmental sustainability, basic needs, leadership in energy and industry, and future economies. These pillars enhance Saudi Arabia's global competitiveness and leadership, aligning with Vision 2030’s objectives to bolster its position as the region's largest economy and the fastest-growing, most robust healthcare sector.
THE SAUDI GOVERNMENT HAS PRIORITIZED INNOVATION BY ALLOCATING A SUBSTANTIAL PORTION OF THE BUDGET TO RESEARCH, DEVELOPMENT, AND SOCIAL ADVANCEMENT. THE RISING DEMAND ON THE HEALTHCARE SECTOR DURING THE PANDEMIC FURTHER PUSHED INNOVATION FORWARD TO SUSTAIN THE SECTOR'S TECHNICAL QUALITY.
Many people believe that medical care is the primary determinant of overall health. However, the truth is that medical interventions account for only about 10% of what keeps us healthy. The most significant impact on our wellbeing comes from our behaviors and lifestyle choices—such as diet, exercise, and stress management—which influence 40% of our health outcomes. Genetics also plays a crucial role, contributing to 30%.
At IGH Clinic, we understand these multifaceted influences on health and embrace a comprehensive approach that goes beyond simply treating illness. This comprehensive approach forms the foundation of Professor Marwan Ghosn's vision at IGH Clinic.
Precision health is an innovative approach that combines genomics data with environmental and behavioral information to create personalized health strategies. This methodology allows us to go beyond treating existing conditions; we also focus on preventing disease in healthy individuals. By analyzing each person’s unique genetic makeup, lifestyle, and environment, we gain a complete picture of their health. Under the leadership of Prof. Ghosn, our medical team has been at the forefront of implementing this cutting-edge approach.
Professor Marwan Ghosn’s commitment to patient-centric care has been instrumental in
PROFESSOR
MARWAN GHOSN’S COMMITMENT TO PATIENT-CENTRIC CARE HAS BEEN INSTRUMENTAL IN DEVELOPING AND APPLYING PERSONALIZED STRATEGIES AT IGH CLINIC.
developing and applying personalized strategies at IGH Clinic. Unlike generic health advice, precision health offers:
Targeted Preventive Care: We identify individual health risks and conditions to offer specific preventive measures.
Early Detection: Advanced molecular screening and biomarker analysis enable the early detection of potential health issues.
Precise Diagnosis: We focus on uncovering the root causes of conditions rather than merely treating symptoms.
Personalized Treatment Plans: Our interventions occur at the molecular level, tailored to the unique genetic profile of each patient.
At IGH Clinic, our multidisciplinary medical team crafts individualized health plans based on a patient’s genetic profile, behaviors, and environmental exposures. This proactive approach empowers our patients to optimize their well-being, moving beyond one-size-fits-all
solutions to achieve healthier living.
Professor Marwan Ghosn, who practices medicine in both Beirut and the UAE, brings a wealth of experience to IGH Clinic. With a multidisciplinary medical team, Professor Ghosn incorporates the latest medical advancements from both regions, further refining our precision health approach.
Technological advancements have made precision health a reality in clinical settings: Next-Generation Sequencing (NGS): This technology allows us to gather detailed genomic information, particularly for complex diseases like cancer and infections, guiding personalized treatment plans.
Gut Microbiome Profiling: For healthy individuals, this genomic analysis provides insights into factors impacting immunity and overall well-being.
OUR MULTIDISCIPLINARY MEDICAL TEAM CRAFTS INDIVIDUALIZED HEALTH PLANS BASED ON A PATIENT’S GENETIC PROFILE, BEHAVIORS, AND ENVIRONMENTAL EXPOSURES. THIS PROACTIVE APPROACH EMPOWERS OUR PATIENTS TO OPTIMIZE THEIR WELL-BEING, MOVING BEYOND ONE-SIZEFITS-ALL SOLUTIONS TO ACHIEVE HEALTHIER LIVING.
Cell-Free DNA Testing: This technology enables early cancer screening by detecting trace amounts of tumor DNA in the bloodstream.
Epigenetic Testing: We measure how lifestyle and environmental factors interact with genes to influence health.
By 2030, genomic analysis is expected to become standard in healthcare. At IGH Clinic, we already offer genetic profiling, microbiome testing, cell-free DNA cancer screening, and epigenetic testing. We aim to leverage cuttingedge, evidence-based technologies to empower patients in their journey toward optimal health. Professor Ghosn’s leadership has been pivotal in adopting these cutting-edge tools at IGH Clinic.
The Four Pillars of Precision Health at IGH Clinic
Our precision health approach is guided by four
key goals. Under the stewardship of Professor Marwan Ghosn, who practices in both Beirut and the UAE, we are committed to empowering individuals with integrated medical strategies for healthier living.
1. Prevention: Utilizing technology to detect early disease markers, enabling proactive interventions before symptoms arise.
2. Prediction: Assessing genetic and lifestyle risk factors to predict potential diseases and treatment responses.
3. Participation: Encouraging patients to take an active role in their health, fostering collaboration with healthcare providers.
4. Personalization: Enhancing health outcomes through individualized care plans tailored to each patient’s condition and genetic/ lifestyle factors.
Our medical team provides precision health care to help patients improve their health.
OUR GOAL IS TO LEVERAGE THESE ADVANCED, EVIDENCE-BASED TECHNOLOGIES TO EMPOWER PATIENTS IN THEIR PURSUIT OF BETTER HEALTH. PROFESSOR GHOSN’S LEADERSHIP HAS BEEN PIVOTAL IN ADOPTING THESE CUTTING-EDGE TOOLS AT IGH CLINIC
Are you ready to experience a new, approach to healthcare? IGH Clinic is here to guide you on this journey. Visit our website at ighclinic.com to learn more about our precision health services and book your first appointment. You can also reach out to our team directly: info@ighclinic.com
OUR PRECISION HEALTH APPROACH IS GUIDED BY FOUR KEY GOALS. UNDER THE LEADERSHIP OF PROFESSOR MARWAN GHOSN, WHO PRACTICES IN BOTH BEIRUT AND THE UAE, WE ARE COMMITTED TO EMPOWERING INDIVIDUALS WITH INTEGRATED MEDICAL STRATEGIES FOR HEALTHIER LIVING.
WWW.IGHCLINIC.COM
Dr. Rafif Tayara, Pediatric Dentist & Oral Health
Dr. Rafif Tayara, a Pediatric Dentist and Oral Health Speaker with extensive experience, is passionate about promoting oral health education and actively raising awareness in the community. Based in Dubai, she offers functional and integrative oral healthcare and early corrective orthodontics, focusing on the whole-body health and wellbeing of babies and children. To help children feel comfortable during their first dental visit, Dr. Tayara authored a children's book titled "Danny and Sarah Go to Dr. Smile." This book serves as a valuable resource for parents to prepare their children for a positive dental experience. It is a great tool to eradicate dental phobia, often transferred from parents to children.
Could you share your journey into pediatric dentistry? What inspired you to specialize in this field?
I had an amazing pediatric dentist during my childhood in Canada, which made visiting the dentist a fun and positive memory for me. Growing up, my mother always saw a future for me in the medical field, though she wasn't sure why. She recognized in me qualities such as calmness, observation skills, curiosity, and strong communication abilities—traits she felt were well suited for a career in healthcare. She even registered me for the Dental School qualifying exam, and I was selected.
My journey into dentistry began there, but my passion for pediatric dentistry truly blossomed when I observed a pediatric dentist treating sick children at one of the largest children's hospitals in Canada. At that moment, I knew this was the path I wanted to pursue.
What is your philosophy when it comes to treating children? How do you create a comfortable and welcoming environment for young patients?
I believe in treating the whole child, not just their mouth or teeth. My philosophy involves understanding the child's overall lifestyle,
habits, health status, breathing and dietary patterns, and their family and social life. This comprehensive approach allows me to address the root cause of any oral and facial issues.
Our clinic is designed to be a place where children feel at ease. The environment is colorful, engaging, and fun, with movies, music, games, books, and even pleasant scents contributing to a positive experience. My little patients become my little friends, and we work to create a "dental home" for them. It's all about engaging their senses and building a long-term positive relationship so that they always look forward to visiting the dentist.
Can you discuss your approach to handling dental anxiety in children? Dental phobia in children often has a root cause; it often starts with adults—parents and caregivers—who may have had negative experiences themselves. Many parents unknowingly transfer this anxiety to their children by using phrases like, "Behave, or I will take you to the dentist," or "Brush your teeth, or the dentist will remove them." These statements create fear and perpetuate a cycle of dental anxiety.
One of the most effective ways to prevent or reduce dental anxiety is to start dental visits early—ideally when the first tooth appears. This
DENTAL PHOBIA ISN'T JUST AN ISSUE IN CHILDREN; IT OFTEN STARTS WITH ADULTS—PARENTS AND CAREGIVERS— WHO MAY HAVE HAD NEGATIVE EXPERIENCES THEMSELVES. MANY PARENTS UNKNOWINGLY TRANSFER THIS ANXIETY TO THEIR CHILDREN BY USING PHRASES LIKE, "BEHAVE, OR I WILL TAKE YOU TO THE DENTIST," OR "BRUSH YOUR TEETH, OR THE DENTIST WILL REMOVE THEM."
initial visit sets the foundation for a healthy and happy smile. To help with this, I've published a children's book called "Danny and Sarah Go to Dr. Smile", which parents can read to their children to prepare them for their first trip to the dentist.
You're one of the first Invisalign First providers in the Middle East. Can you elaborate on the importance of early orthodontic intervention?
Early orthodontic intervention is at the core of my daily practice. It's essential to detect growth issues early—issues that sometimes even their doctors might not notice—and intervene to guide healthy development.
For example, parents often think it's cute when a child sleeps with their mouth open or snores, but these can be signs of underlying issues, as an airway obstruction or an iron deficiency. Early detection allows us to address these problems, such as by improving tongue posture or referring the child to an ENT specialist. Sometimes, we may need to expand the child's jaws to improve breathing, growth, and mental health. Children who breathe through their mouths often struggle with fatigue, dark circles under their eyes, and difficulty concentrating, sometimes leading to a misdiagnosis of ADHD. Early orthodontic correction can lead to healthier growth, better sleep quality, and happier, more focused individuals in the long run.
What key oral health messages do you hope children will take away from your book?
The key messages I hope to convey through my book are:
• The dentist is fun!
• My smile is the gateway to my body and my door to the world.
• Smiling with healthy teeth makes me happy!
When should parents start taking care of their baby's oral hygiene?
Women should get their mouth and teeth checked before planning for pregnancy, as oral health issues in a pregnant woman may lead to a miscarriage and pre-term birth. When the
baby is born, oral hygiene starts before the first tooth appears by daily cleaning the baby's mouth, gums, and inner cheeks with a clean, wet wipe or gauze. When the first few teeth come in, switch to a baby toothbrush with a smear of toothpaste and brush your baby's teeth daily. This practice not only keeps the mouth clean but also establishes a habit that will last a lifetime.
Can you discuss the different types of orthodontic treatments available for children?
In my practice, we offer early interceptive orthodontics when necessary to correct issues with the jaws, bite, or spacing between teeth. We also offer clear aligners, which are a great option for children who haven't yet lost all their baby teeth but need early correction. These aligners are increasingly popular among teenagers due to their aesthetic appeal and are particularly beneficial for those with poor oral hygiene. We also provide fixed braces for teenagers who prefer traditional metallic braces. Depending on the child's needs, we may use removable appliances, clear aligners, fixed expanders, habit-breaking appliances, or brackets. Early intervention is key, as treating issues early allows the jaws to grow optimally and boosts the child's self-confidence.
Dr. Tayara's holistic and child-centered approach to pediatric dentistry ensures that her patients not only receive the best care but also develop a positive relationship with dental health that lasts a lifetime. Her expertise in early orthodontic intervention further supports the healthy growth and well-being of her young patients.
OUR CLINIC IS DESIGNED TO BE A PLACE WHERE CHILDREN FEEL AT EASE. THE ENVIRONMENT IS COLORFUL, ENGAGING, AND FUN, WITH MOVIES, MUSIC, GAMES, BOOKS, AND EVEN PLEASANT SCENTS CONTRIBUTING TO A POSITIVE EXPERIENCE. MY LITTLE PATIENTS BECOME MY LITTLE FRIENDS, AND WE WORK TO CREATE A "DENTAL HOME" FOR THEM. IT'S ALL ABOUT ENGAGING THEIR SENSES AND BUILDING A LONGTERM POSITIVE RELATIONSHIP SO THAT THEY ALWAYS LOOK FORWARD TO VISITING THE DENTIST.
Each year, millions of patients undergo root canal treatment, which helps them eliminate severe pain and preserve their teeth from potential decay and extraction due to infection. Root canal procedures are successful in 86-98% of cases, meaning the vast majority of patients experience excellent results. However, like any medical procedure, root canals can occasionally fail for various reasons, such as persistent infection due to incomplete cleaning or sealing of the root canal or patients not following post-procedure instructions. Therefore, recognizing the signs of root canal failure early is crucial for proper management.
Contact your dentist immediately if you experience any of the following signs, which may indicate a failed root canal or the development of an infection after the procedure:
• Severe and persistent tooth pain, especially when pressure is applied. It's normal to feel mild to moderate pain after a root canal, which may last a few days, but prolonged, intense pain that prevents you from eating, chewing, or speaking normally is concerning.
• Swelling or inflammation of the gums around the treated tooth.
• Formation of an abscess filled with pus near the tooth’s root or surrounding gum tissue.
• Discoloration of the tooth.
• Swelling on the side of the face or neck near the treated tooth.
• Prolonged sensitivity to hot or cold, or even mild pressure.
• A foul taste or persistent bad breath.
If you experience any of the above symptoms after a root canal, it is critical to see your dentist as soon as possible. Be aware that signs of treatment failure may not appear immediately;
they could surface shortly after the procedure or even years later.
Your dentist will examine the tooth and take X-rays to determine the cause of the problem. They will then treat any infection or issues in the root canal before symptoms worsen.
When traditional root canal treatment fails or if the infection persists, your dentist may resort to the following options:
The dentist may perform a second cleaning
AL AHLI HOSPITAL’S DENTAL CLINICS ARE THE IDEAL PLACE TO RECEIVE TOP-QUALITY ROOT CANAL TREATMENT WITH THE HIGHEST LEVEL OF CARE
and filling of the root canal to remove any remaining infection.
In some cases, minor surgery may be required to remove the infected part of the root.
If the tooth is severely damaged and other treatments fail, extraction may be the last resort, followed by the placement of a dental implant or bridge.
For a smooth recovery without complications, follow your dentist’s post-root canal care instructions. Here are some helpful tips:
• Eat soft foods during the first few days, such as mashed potatoes, cottage cheese, smoothies, and yogurt.
• Avoid chewing directly on the treated tooth, and try to chew on the other side of your mouth.
• Temporarily quit smoking, even for a short period.
• Brush your teeth regularly and use dental floss once a day.
• Use an antibacterial mouthwash to maintain oral hygiene.
Our team possesses advanced knowledge and extensive experience in treating root canal issues, ensuring you receive the best possible outcomes.
Don't worry about sudden pain or emergencies—our dental services are available around the clock to meet your needs anytime.
We utilize the latest dental technology for accurate diagnosis, effective treatment, and optimal results.
Our clinics are designed to provide a comfortable, state-of-the-art environment, ensuring you feel at ease throughout your visit.
We offer our services at reasonable rates to suit all budgets without compromising quality.
In summary, Al Ahli Hospital’s dental clinics are the ideal place to receive top-quality root canal treatment with the highest level of care. Why wait? Book your appointment now and enjoy a healthy, beautiful smile!
BE AWARE THAT SIGNS OF TREATMENT FAILURE MAY NOT APPEAR IMMEDIATELY; THEY COULD SURFACE SHORTLY AFTER THE PROCEDURE OR EVEN YEARS LATER.
Clemenceau Medical Center (CMC), in affiliation with Johns Hopkins Medicine International, stands as a state-of-the-art medical institution at the heart of Beirut. It is a beacon of quality healthcare services not only in Lebanon but across the Middle East and beyond. Renowned for its commitment to excellence, CMC offers superior healthcare through its affiliation with Johns Hopkins Medicine and multiple accreditations by the Joint Commission International (JCI).
Pioneering Healthcare Excellence with Cutting-Edge Innovations
At Clemenceau Medical Center, we are dedicated to pioneering healthcare excellence through the integration of cutting-edge innovations. Our commitment to advanced technology and patient care sets us apart in the medical field.
Advanced Diagnostic Imaging
Latest technology for accurate diagnostics.
Automated Laboratory System
Optimized lab operations for quicker results.
AI Software Integration
Artificial intelligence for improved diagnostics and personalized care.
Next Generation Sequencing (NGS)
Advanced genetic analysis for targeted treatments.
Robotic Surgery
Minimally invasive procedures with quicker recovery.
Patient Engagement and Safety Innovations
Enhanced interaction, safety, and operational efficiency.
Celebrating Excellence: Sixth JCI Accreditation
In January 2024, Clemenceau Medical Center
AT CLEMENCEAU
MEDICAL CENTER, WE ARE DEDICATED TO PIONEERING HEALTHCARE EXCELLENCE THROUGH THE INTEGRATION OF CUTTING-EDGE INNOVATIONS. OUR COMMITMENT TO ADVANCED TECHNOLOGY AND PATIENT CARE SETS US APART IN THE MEDICAL FIELD.
proudly celebrated its sixth accreditation by the Joint Commission International (JCI). This prestigious recognition underscores CMC's unwavering commitment to delivering superior healthcare services and maintaining the highest standards of patient care and safety.
The achievement highlights the center's dedication to continuous improvement, innovation, and excellence in all aspects of medical service. This milestone reaffirms CMC's position as a leading healthcare institution in the Middle East and beyond, setting new benchmarks in quality healthcare.
CMC houses all specialty branches, diagnostic services, and outpatient clinics, operating within a film-less digital medical imaging environment. The center’s modern Operating Theaters feature advanced laparoscopy and OR automation systems, setting new standards in surgical precision and efficiency. CMC has been at the forefront of introducing robotic surgery and cutting-edge technology in Radiation Oncology in the Middle East, boasting remarkable success rates in these advanced procedures.
A testament to CMC’s pioneering spirit is its introduction of Next Generation Sequencing (NGS). This revolutionary technology enables precise and rapid analysis of genetic material, offering results within 14 days—significantly faster than the traditional 45-day period required for overseas processing.
NGS enhances disease diagnosis, improves the prediction of genetic risks, and allows for the formulation of personalized treatment plans, particularly in cancer care.
The center is also recognized for its state-of-the-art automated laboratory system, which integrates cutting-edge technologies to ensure precision, quality, and reliability across all tests.
Facilitates convenient access to medical records and appointment scheduling.
The recent implementation of the RLDatix system marks a new frontier in patient safety management and risk administration. This advanced platform elevates patient safety through enhanced incident reporting, risk management, and quality improvement module.
CMC continuously invests in updating its medical equipment and adopting the latest
IN JANUARY 2024, CLEMENCEAU MEDICAL CENTER PROUDLY CELEBRATED ITS SIXTH ACCREDITATION BY THE JOINT COMMISSION INTERNATIONAL (JCI). THIS PRESTIGIOUS RECOGNITION UNDERSCORES CMC'S UNWAVERING COMMITMENT TO DELIVERING SUPERIOR HEALTHCARE SERVICES AND MAINTAINING THE HIGHEST STANDARDS OF PATIENT CARE AND SAFETY.
technologies. Its radiological diagnostic devices and equipment, now enhanced with artificial intelligence techniques, provide unparalleled diagnostic accuracy and efficiency.
The center’s Cardiology Unit features the CVI42 Cardiac MR, an AI-based platform that optimizes decision making and increases productivity in cardiac imaging. Among CMC’s cutting-edge imaging technologies are:
A leading MRI system providing exceptional image quality and integrated AI for advanced image reconstruction, reducing scan time by more than 50%.
This innovative platform offers exceptional technology, delivering fast image acquisition, less radiation dose, and minimal preparation time.
A digital mammography system
Designed to enhance patient experience through improved procedures and comfort measures.
Logiq Fortis: Cutting-edge ultrasound system
Provides exceptional image quality that surpasses standards and includes integrated AI for advanced image reconstruction.
These advancements in radiology and diagnostic imaging offer numerous benefits:
• Enhanced patient experience through improved procedures and comfort measures.
• Exceptional image quality that surpasses standards.
• Integrated artificial intelligence for advanced image reconstruction.
• Reduced scan time by more than 50%.
• Many exams require no preparation.
• Increased comfort and reduced stress during difficult exams.
• Allow for walk-in service all day long.
• Outstanding image quality, surpassing expectations.
• Better image resolution.
• Faster and easier exams.
• Increased accuracy and detection of small cancers.
Clemenceau Medical Center is dedicated to continuous improvement and innovation in healthcare. By adopting the latest medical technologies and updating equipment, CMC significantly enhances the quality of healthcare services provided. This comprehensive approach, combined with cutting-edge technological advancements, establishes CMC's position as a leader and pioneer in the Middle East and beyond. In conclusion, CMC remains at the forefront of medical innovation, offering state-of-the-art healthcare services that ensure patients receive the highest quality care, making it a true leader in the region
The department of radiation oncology at CMC features a TrueBeam STx with Brainlab Exactrac imaging and robotic couch, in addition to the Eclipse treatment planning system and Brainlab Elements for radiosurgery planning. The department has been Novalis-certified since 2018. Starting in September 2024, the department will undergo an upgrade to Brainlab Exactrac Dynamic, Perfect Pitch robotic couch, the newest version of the Aria oncology information system, and Novalis recertification. This upgrade will enable:
• Faster patient setup
• Tattoo-free, less invasive treatments
• Patients spending less time in the treatment room
• Accurate targeting and submillimeter tracking and positioning
• Increased dose delivery and subsequent reduction in the number of sessions
• More patients to be treated in the same working hours
THE DEPARTMENT OF RADIATION ONCOLOGY AT CMC FEATURES A TRUEBEAM STX WITH BRAINLAB EXACTRAC IMAGING AND ROBOTIC COUCH
Dr. Matteo Vigo is a highly esteemed plastic surgeon with a distinguished career specializing in breast aesthetic and reconstructive surgeries. After graduating from Milan in 2004, Dr. Vigo honed his skills during his residency at the Ospedale Maggiore Borgo Trento in Verona, where he developed expertise in breast reconstruction and the full spectrum of plastic surgery procedures. He currently holds esteemed positions as the Medical Director at Amwaj Polyclinic in JBR, Dubai, and as a Plastic Surgeon at Health
Bay Polyclinic. Renowned for his advanced techniques in breast surgery, Dr. Vigo is one of the few surgeons in the UAE authorized to perform the innovative Mia Femtech™ technique. His work is characterized by a deep commitment to patient care, ensuring that each individual receives personalized attention and support throughout their surgical journey.
Dr. Vigo’s dedication, attention to detail, and compassionate approach, combined with his continuous pursuit of the latest advancements in regenerative medicine and plastic surgery,
DR. VIGO IS ONE OF THE FEW SURGEONS IN THE UAE AUTHORIZED TO PERFORM THE INNOVATIVE MIA FEMTECHTM TECHNIQUE.
make him a trusted and sought-after expert in the field. His motto, “…because you deserve the best,” reflects his unwavering commitment to providing the highest quality care to his patients. Dr. Vigo shared the new breast enhancement technique Mia Femtech™, with ‘Hospitals’ magazine.
What elements in the field of plastic surgery continue to fascinate and motivate you?
As an Italian with a deep appreciation for beauty and fashion, I've always been drawn to the field of plastic surgery. I was surrounded by the country's rich history and its influence on aesthetics. This exposure cultivated my own sense of style and appreciation for the artistry of beauty. What truly excites me about plastic surgery is its unique ability to merge art and science. It allows me to provide my patients with exceptional results that not only meet but often exceed their expectations. By combining my own concept of beauty with the latest technological advancements, I can create personalized treatment plans that cater to everyone’s unique needs and desires.
One of the most rewarding aspects of my work is the connection I build with my patients. It's more than just a doctor-patient relationship; it's a unique experience that I strive to create for everyone. I often maintain contact with my patients after their surgery, fostering a lasting relationship beyond the initial procedure.
Why do most women seek breast surgery, and how do you customize your approach to address their unique needs?
Women often seek breast surgery to enhance their self-esteem and achieve a breast shape that aligns with their desired aesthetic. Factors such as pregnancy, breastfeeding, weight fluctuations, and puberty can significantly alter breast appearance, leading many women to explore surgical options.
As a plastic surgeon, I tailor my approach to each patient's individual needs and goals. I understand the impact that breasts can have on a woman's self-image and identity. By carefully considering factors like desired outcome, breast shape, overall body proportions, and personal
preferences, I can develop a personalized treatment plan that addresses the patient's specific concerns and helps them achieve their ideal breast appearance.
I believe that a successful breast surgery outcome goes beyond simply achieving a desired shape. It's about enhancing a woman's confidence, improving her overall wellbeing, and helping her feel empowered in her own body. By taking a holistic approach and considering the patient's emotional and psychological needs, I strive to create a positive and transformative experience.
Can you describe the Mia FemtechTM technique for breast harmonization, and what makes Mia® a preferred choice among consumers?
The Mia® technique is a revolutionary advancement in breast harmonization, offering a minimally invasive and highly effective approach to enhancing breast volume and shape. As the first injectable implant, Mia® allows for a quick and comfortable procedure with a rapid recovery time.
Through a small incision in the armpit, the unique diamond-shaped implant is inserted above the muscle. This innovative design enables significant volume enhancement, even with smaller implant sizes, providing a naturallooking and harmonious result.
One of the most remarkable aspects of Mia® is the minimal downtime it requires. Women can return to their normal activities within a few days of the procedure, allowing them to quickly resume their daily routines. Some ladies have even been able to travel or return to work shortly after the procedure, demonstrating the exceptional convenience of this technique.
Mia® is ideal for those seeking a subtle and natural-looking breast enhancement.
The results are subtle and harmonious, creating a more natural appearance that is virtually undetectable. By avoiding the need for padded or push-up bras, Mia® allows women to feel confident and comfortable in their bodies.
What steps are involved in becoming a Mia®-certified surgeon? And why does a surgeon need to be certified?
ONE OF THE MOST REMARKABLE ASPECTS OF MIA® IS THE MINIMAL DOWNTIME IT REQUIRES. WOMEN CAN RETURN TO THEIR NORMAL ACTIVITIES WITHIN A FEW DAYS OF THE PROCEDURE, ALLOWING THEM TO QUICKLY RESUME THEIR DAILY ROUTINES. SOME LADIES HAVE EVEN BEEN ABLE TO TRAVEL OR RETURN TO WORK SHORTLY AFTER THE PROCEDURE, DEMONSTRATING THE EXCEPTIONAL CONVENIENCE OF THIS TECHNIQUE
To become a Mia®-certified surgeon, one must undergo a rigorous process administered by Establishment Labs, the company behind the implants. Given the innovative and specialized nature of the Mia® procedure, the company requires that only highly experienced and skilled plastic surgeons be certified to perform it.
The certification process involves applying your qualifications and experience in breast surgery. The company then reviews these applications and selects qualified candidates for further training. The training typically takes place at a designated training center and includes both theoretical and practical components. Once certified, surgeons are required to perform their first few cases
under the supervision of a qualified trainer. This ensures that they have a thorough understanding of the procedure and can safely apply it to their patients.
We hear that a woman can preserve her breast tissue during the Mia® procedure. What does that mean?
One of the most significant advantages of the Mia® technique is its ability to preserve breast tissue. Unlike traditional breast augmentation methods that involve cutting and manipulating breast tissue, Mia® utilizes a non-invasive approach that avoids damaging the surrounding tissue.
Instead of cutting through the breast tissue,
TO BECOME A MIA®-CERTIFIED SURGEON, ONE MUST UNDERGO A RIGOROUS PROCESS ADMINISTERED BY ESTABLISHMENT LABS, THE COMPANY BEHIND THE IMPLANTS
Mia® employs a balloon that is gently inflated to create space for the implant. This technique eliminates the need for tissue dissection, preserving the integrity of the breast tissue, nerves, and blood vessels.
By preserving breast tissue, Mia® offers several benefits. It reduces the risk of complications associated with tissue trauma, minimizes changes to nipple sensation, and facilitates future mammograms for breast cancer screening.
This non-invasive approach ensures that the breast remains healthy and functional, even after the procedure.
You have done several numbers of cases, what was the feedback from the consumers?
The feedback has been overwhelmingly positive. On average, consumers rate the outcome of Mia® procedure as 9.5 out of 10. This exceptional satisfaction rate demonstrates the effectiveness and benefits of the Mia® technique in achieving natural-looking and aesthetically pleasing results.
What can you say to women who are skeptical about such an innovative technology and are used to breast augmentation?
While Mia® technique offers many advantages, it's important to understand that it's not suitable for everyone. Traditional breast augmentation may be more appropriate for women seeking larger implants or significant shape modifications.
Mia® is ideal for women who desire a natural-looking breast enhancement without the need for extensive surgery or prolonged recovery. It's particularly well-suited for those who are hesitant about general anesthesia or prefer a less invasive approach. As a plastic surgeon, I carefully assess each woman's individual needs and goals to determine the most suitable procedure.
Some consumers may require more extensive tissue manipulation, such as addressing asymmetry or correcting sagging breasts, which can be achieved more effectively through traditional techniques.
Many women wonder if the Mia® procedure is safe. What can you tell them?
The Mia® procedure is a remarkably safe technique due to its non-invasive nature. As a blunt technique, it involves no cutting or tissue dissection, significantly reducing the risk of bleeding and complications. The recovery time for Mia® is exceptionally fast.
The safety of Mia® is further enhanced by careful consumer selection. When performed on suitable candidates, the risk of complications is extremely low. Overall, Mia® offers a safe and effective approach to breast augmentation with minimal downtime and a rapid recovery.
While it's rare and uncommon, a woman might decide to get explanted after a Mia® procedure. In such cases, the implant can be safely removed through a minimally invasive technique that uses the same incision as the original procedure.
The removal process involves aspirating the implant, which, due to its relatively small size, does not significantly disrupt the breast tissue. This allows the woman to return to their preprocedure state.
The company that manufactures Mia® implants typically offers a lifetime warranty in addition to a two-year initial coverage. This means that if a woman wants to opt out and get explanted within two years, the company will cover the cost of implant removal.
What warranty does the Mia® procedure offer, and how are consumers covered?
Mia® implants are designed to be highly durable and resistant to complications such as rupture and capsular contracture. This durability is backed by an extensive warranty offered by the company.
The success of Mia® procedure depends on choosing the best candidate. While Mia® is a safe and effective technique, it's important to consult with a qualified surgeon who has experience with this procedure.
By choosing a qualified Mia® surgeon and understanding the procedure's suitability for your individual needs, you can increase your chances of a successful and satisfying outcome.
MIA® IS IDEAL FOR WOMEN WHO DESIRE A NATURALLOOKING BREAST ENHANCEMENT WITHOUT THE NEED FOR EXTENSIVE SURGERY OR PROLONGED RECOVERY. IT'S PARTICULARLY WELLSUITED FOR THOSE WHO ARE HESITANT ABOUT GENERAL ANESTHESIA OR PREFER A LESS INVASIVE APPROACH. AS A PLASTIC SURGEON, I CAREFULLY ASSESS EACH WOMAN'S INDIVIDUAL NEEDS AND GOALS TO DETERMINE THE MOST SUITABLE PROCEDURE.
Adele Chedraoui, Consultant Dermatologist at Al-Ahli Hospital/Qatar
Hair loss is a natural part of the hair cycle, with most people losing 50100 hairs daily without even noticing. However, excessive hair loss can indicate an underlying issue that requires attention. This article explores the common causes of hair loss, treatment options, and preventive measures.
The hair growth cycle begins deep in the scalp and ends when the hair falls out. This cycle consists of three main phases:
1. Anagen (Growth Phase):
The longest phase, lasting up to six years or more, during which the hair grows quickly and reaches its full length. Most of the hair on your head is in this phase.
2. Catagen (Transitional Phase)
A short 2-3 weeks phase when the hair stops growing and the hair follicles start shrinking.
3. Telogen (Resting Phase)
Lasting 1-4 months, this phase sees some hair
THE HAIR GROWTH CYCLE BEGINS DEEP IN THE SCALP AND ENDS WHEN THE HAIR FALLS OUT.
detaching from the follicle, ready to fall out as new hair starts to grow in its place.
This cycle can be affected by factors such as genetics, nutrition, hormones, illnesses, and stress.
1. Genetic Hair Loss:
Genetic hair loss, also known as androgenetic alopecia, is the most common cause. It can begin at any age after puberty, though it often appears later in life. Women typically experience thinning hair at the top of the scalp, while men may notice a receding hairline or bald patches.
Treatment: Unfortunately, there is no cure for genetic hair loss. However, treatments like minoxidil (Rogaine), finasteride (Propecia), or hair transplants can slow down the process and stimulate new hair growth.
2. Aging:
As people age, hair growth slows, leading to thinning or receding hairlines.
Treatment:The same options for treating genetic hair loss apply, including minoxidil and hair transplants.
3. Hormonal Changes:
Hormonal fluctuations during pregnancy, childbirth, menopause, or due to thyroid issues or polycystic ovary syndrome (PCOS) can lead to hair loss.
Treatment: Addressing the underlying hormonal imbalance, such as taking hormoneregulating medications or thyroid treatments or using spironolactone (Aldactone) in cases of PCOS.
4. Nutritional Deficiencies:
A lack of essential vitamins and minerals, such as iron, zinc, biotin, or protein, can weaken hair follicles and lead to hair loss.
Treatment: Improving your diet to include foods rich in these nutrients or taking supplements if blood tests reveal a deficiency.
5. Stress and Emotional Strain:
Chronic stress or recovering from illness, surgery,
or childbirth can cause a condition called telogen effluvium, where hair sheds excessively.
Treatment: Managing stress through relaxation techniques like yoga, meditation, regular exercise, and, if necessary, cognitivebehavioral therapy (CBT). Hair typically regrows 6-9 months after the stress is resolved.
Certain medications, such as those for cancer, depression, or high blood pressure, can have hair loss as a side effect. Additionally, skin conditions like alopecia, fungal infections, or autoimmune diseases can contribute to hair loss.
Treatment: Your doctor may adjust your medication dosage or switch to an alternative drug, and skin conditions may require specific treatments like corticosteroids or antifungals.
• Wash your hair regularly with gentle shampoo and conditioner suitable for your hair type.
• Avoid hot oil treatments or excessive heat, as they can weaken and damage hair.
• Gently brush or comb your hair, allowing it to air dry when possible.
• Quit smoking, as it negatively impacts hair health.
• Massage your scalp for 5-10 minutes daily to promote circulation.
• Consider growth-stimulating treatments such as platelet-rich plasma (PRP) or laser therapy.
Contact a healthcare professional if you experience scalp irritation, itching, burning, sudden or significant hair loss, or hair loss across your entire body. To maintain your hair’s health and vitality, book an appointment with the Dermatology Department at Al Ahli Hospital. We offer precise diagnoses and personalized treatments to address your hair concerns.
CONTACT A HEALTHCARE PROFESSIONAL IF YOU EXPERIENCE SCALP IRRITATION, ITCHING, BURNING, SUDDEN OR SIGNIFICANT HAIR LOSS, OR HAIR LOSS ACROSS YOUR ENTIRE BODY. TO MAINTAIN YOUR HAIR’S HEALTH AND VITALITY, BOOK AN APPOINTMENT WITH THE DERMATOLOGY DEPARTMENT AT AL AHLI HOSPITAL. WE OFFER PRECISE DIAGNOSES AND PERSONALIZED TREATMENTS TO ADDRESS YOUR HAIR CONCERNS.
The lateral tilt, the distinctive LINET feature, is placed on permanent duty in hospitals and long-term care. LINET delivers an advanced solution that is effective, safe, and of high quality because it complies with the most stringent EU/US and other globally recognized standards.
Easy patient positioning
Therapeutical support
Safety for both, patient and caregivers
Certified EU quality
LEARN MORE ABOUT MULTICARE X AND ESSENZA 300 AT GLOBAL HEALTH EXHIBITION 2024
LINET booth H2B-S20, Looking forward to meeting you in Riyadh, KSA
• Bed-framed lateral rotation by Multicare X bed is available at the maximal angle of 30° left and 30° right.
• The lateral tilt movement can be programmed in cycles according to individual patient needs.
• Together with a non-invasive, radiation-free electrical impedance tomography (EIT) monitor can be used in continuous, individualized ventilation care.
30° left and 30° right
Monitor EIT as a non-invasive monitoring system provides real-time functional lung monitoring.
Multicare® X with ALT Precise and individual adjustment of the lateral tilt allows you to change the ventilation distribution and helps with lung collapse.
• Lateral tilt turns into a new gold standard in acute care reducing physical strains on the caregiver by 67%.
• Lateral tilt simplifies daily procedures such as skin assessment, patient hygiene, positioning, bed making, transfer from the bed to the stretcher, and also in the mobilization process.
less than 67% of forces needed for turning the patient
Memorial Hospitals Group, founded in 2000, stands as a titan in the Turkish medical landscape, offering exceptional healthcare services across the nation. With a network of 11 hospitals in total (10 hospitals and 3 medical centers spanning 6 cities in Turkey, and 1 hospital in Romania), along with representative offices reaching far beyond Turkey's borders, Memorial has established itself as a leader in patient-centered care and medical innovation. Our aim is to solidify our commitment to expanding access to high-quality healthcare by increasing the number of our hospitals, including our ongoing projects in the Esenyurt and Göztepe districts of Istanbul.
We are expanding our footprint in Türkiye & The Region
We are acquiring A+ hospitals outside of Türkiye
Memorial Romania
11.000 m2 Closed Area / 106 Bed Capacity
6 Operating Rooms / 12 Intensive Care
Memorial’s mission
We are building hospitals of the future in Türkiye
Memorial Göztepe
300 Bed Capacity
53 Intensive Care / 133 Polyclinics
To become a world-class healthcare brand by keeping up with scientific and technological advancements, maintaining ethical principles, and making a difference with pioneering practices. We aim to ensure satisfaction for patients, their families, and our employees while upholding to international quality standards.
First hospital in Turkey to receive the JCI Accreditation Quality Certificate (Joint Commission International), and the 21st globally.
First private hospital in Turkey licensed by the Ministry of Health for organ transplantation (liver and kidney) and related laboratory services in March 2004.
Performed the first pediatric mismatched liver transplant in Turkey.
Conducted the first bloodless liver transplant in Turkey.
First in Turkey to perform organ removal from a liver transplant donor using Vinci Robotic Surgery.
Executed the first robotic kidney transplant in Turkey.
For the first time in Turkey, combined pediatric, robotic, diabetes, and obesity surgeries on a single patient.
Conducted Turkey’s first stitchless corneal transplant.
Prof. Dr. Semra Kahraman, Head of Memorial IVF Center, achieved pregnancy for the first time in Turkey using the microinjection method.
Memorial Healthcare Group's influence extends far beyond Turkey's borders. With representative offices in Azerbaijan, Uzbekistan, Gabon, Bosnia and Herzegovina, Montenegro, Northern Cyprus, Albania, Romania, Georgia, the United Kingdom and others in progress (Iraq, Algeria, Pakistan and Libya), we serve as a bridge, making our world-class healthcare accessible to wider international patients. This translates to treating over 120,000 patients from around the globe each year.
Memorial Healthcare Group is a shining example of how a dedication to quality, innovation, and patient care can revolutionize healthcare. As we continue to push boundaries
Produced heart muscle cells from embryonic stem cells at Memorial Hospital in 2004.
Performed aortic aneurysm surgery using a special technique through a 2cm incision, accomplishing four different procedures in the same session, including the replacement of the patient's aortic valve, aortic root, and aortic valve with the first fully biological structure (Freestyle) endoscopically, and a procedure on the carotid artery.
First hospital in Turkey to utilize advanced methods such as capsule endoscopy and endostent.
Memorial Antalya Hospital is the first IVF center in Turkey accredited by the American Embryology Society.
Memorial Şişli Hospital Tissue Typing and Immunology Laboratory is the first private lab in Turkey accredited by the European Federation for Immunogenetics (EFI).
Memorial Şişli Hospital IVF Laboratory is the first IVF lab in Turkey accredited by TÜRKAK Accreditation Agency according to ISO 15189 standards.
First in Turkey and Europe to perform kidney surgery on a 2.5-month-old baby using robotic surgery.
and reach new heights, one thing remains constant: Memorial will continue to be one of the leaders in Turkey and global healthcare, setting the standard for excellence for years to come.
In today's dynamic healthcare landscape, expansion requires a strategic partner who can guide you every step of the way. Our comprehensive consulting services empower healthcare providers to navigate growth with confidence. We offer a full spectrum of expertise, from feasibility studies and market research to design, construction, and ongoing operational support. Whether you're opening a new facility, expanding an existing one, or optimizing your current operations, we have the tools and knowledge to help you achieve your vision.
67 bed capacity / 21 policlinic / 14 intensive care
OMAN
79 bed capacity / 12 policlinic
64 polyclinic / 18 observation room
35 policlinic / 160 beds
Our consulting business supports our international expansion ambitions
STRATEGIC CONSULTANCY
Business Planning. Financial Modelling. Feasibility Study. Market Research.
DESIGN & CONSTRUCTION CONSULTANCY
Design and Planning. Project & Construction Management. Medical Equipment Planning.
OPS & MANAGEMENT 5 CONSULTANCY
Quality Management & Patient Experience. Human Resources & Training. Information Technologies. Hospitality Services & Facility Management.
In the rapidly evolving field of clinical diagnostics; efficiency, accuracy, and adaptability remain crucial attributes for today’s innovations. Beckman Coulter Diagnostics, a prominent player in the industry, recently unveiled its latest innovation: the DxC 500i Clinical Analyzer. This advanced system, tailored for satellite and independent labs, emphasizes flexibility, scalability, and seamless data integration. By merging advanced chemistry and immunoassay technologies, Beckman Coulter aims to improve laboratory operations and patient care with the DxC 500i Clinical Analyzer.
The DxC 500i Clinical Analyzer is a testament to Beckman Coulter’s commitment to advancing laboratory technology. Positioned ideally for low-volume and independent labs, this analyzer integrates clinical chemistry and immunoassay testing into a single, space-efficient unit, aligning with the growing trend in healthcare towards networked models that enhance efficiency and accessibility.
The DxC 500i Clinical Analyzer integrates the advanced DxC 500 AU Chemistry Analyzer technology, offering Six Sigma-level precision and reliability, with Beckman Coulters’ proprietary immunoassay technology. It can perform up to 800 chemistry tests and 100 immunoassay tests per hour, processing up to 168 samples simultaneously.
Jamie Phares, Senior Vice President of Commercial Operations at Beckman Coulter, emphasized the analyzer’s versatility and impact. “The DxC 500i analyzer is engineered to excel in independent and satellite lab environments. With features like on-the-fly reagent loading and independent operation, it maintains unwavering performance while enhancing operational efficiency. This solution is designed to adapt to the evolving needs of modern laboratories and
THE DXC 500I CLINICAL ANALYZER INTEGRATES THE ADVANCED DXC 500 AU CHEMISTRY ANALYZER TECHNOLOGY, OFFERING SIX SIGMALEVEL PRECISION AND RELIABILITY, WITH BECKMAN COULTERS’ PROPRIETARY IMMUNOASSAY TECHNOLOGY. IT CAN PERFORM UP TO 800 CHEMISTRY TESTS AND 100 IMMUNOASSAY TESTS PER HOUR, PROCESSING UP TO 168 SAMPLES SIMULTANEOUSLY.
support their quest for excellence in diagnostic testing,” Phares stated.
The DxC 500i analyzer features FlexMode operations that prioritize testing by sample urgency and manage repeats and re-runs automatically, optimizing throughput with prompt sample rack changes. Its intuitive interface, with task indicators and step-bystep instructions, simplifies use and training, reflecting Beckman Coulter’s emphasis on practical simplicity.
The DxC 500i Clinical Analyzer supports over 170 preprogrammed assays and utilizes advanced methods such as spectrophotometry, potentiometry, and chemiluminescence for precise results. It integrates chemistry and immunoassay modules to meet various diagnostic needs. The analyzer ensures consistent, high-quality results through quality control mechanisms, including Shewhart management and multi-rule methods, enhancing patient care and reliability.
The DxC 500i analyzer is designed for flexibility and efficiency, featuring continuous operation with on-the-fly reagent and consumable loading to minimize downtime and maximize throughput. Its dynamic sample handler offers flexible STAT options and optimizes turnaround times by prioritizing samples based on urgency. Additionally, the analyzer accommodates various tube types and sizes, including pediatric cups, and handles a wide range of sample types such as serum, plasma, urine, and amniotic fluid.
Find more information on this latest innovation from Beckman Coulter here: https://bit.ly/4bCSNh2
The DxC 500i Clinical Analyzer includes advanced specifications with permanent glass cuvettes for chemistry tests and disposable vessels for immunoassays. It supports various sample container sizes and barcode symbology, providing flexibility for different lab settings. The analyzer also offers substantial reagent storage—76 positions for chemistry reagents and 24 for immunoassay reagents—enabling laboratories to perform a broad range of tests with minimal reloading.
The DxC 500i analyzer requires specific installation and operational conditions, including adequate space for ventilation, weight considerations, and detailed waste and water supply requirements to ensure optimal performance. The analyzer needs a stable power supply and specific temperature and humidity ranges to ensure accurate and reliable test results.
Beckman Coulter Diagnostics is advancing laboratory technology with innovations like the DxC 500i Clinical Analyzer. As healthcare systems move toward integrated approaches, Beckman Coulter leads in enhancing efficiency, accuracy, and patient care.
The DxC 500i exemplifies this mission by combining advanced technology with practical usability, driving progress in diagnostics and improving patient outcomes. Its robust performance, user-friendly interface, and extensive assay menu mark a significant advancement in clinical diagnostics, reflecting Beckman Coulter’s commitment to shaping the future of healthcare diagnostics.
For Beckman Coulter’s worldwide office locations and phone numbers, please visit: www.beckmancoulter.com/contact
© 2024 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 2024 08212024-article-CChem-Other-EM-EN
THE DXC 500I ANALYZER IS DESIGNED FOR FLEXIBILITY AND EFFICIENCY, FEATURING CONTINUOUS OPERATION WITH ON-THE-FLY REAGENT AND CONSUMABLE LOADING TO MINIMIZE DOWNTIME AND MAXIMIZE THROUGHPUT. ITS DYNAMIC SAMPLE HANDLER OFFERS FLEXIBLE STAT OPTIONS AND OPTIMIZES TURNAROUND TIMES BY PRIORITIZING SAMPLES BASED ON URGENCY.
“In an ever-evolving healthcare landscape, staying informed about new developments is essential for delivering high-quality patient care.”
Weill Cornell Medicine-Qatar (WCM-Q) will host its second annual Updates in Primary Care conference on November 29 and 30 in Doha, Qatar. The conference, titled ‘Updates in Primary Care: Specialist-Led Case-Based Discussions Highlighting the Latest Evidence and Best Clinical Practice - 2024,’ reflects WCM-Q’s commitment to delivering cutting-edge, practical education. Organized entirely by graduates of the college, the twoday conference will feature WCM-Q-trained physicians sharing the latest updates in clinical best practices with family physicians, general practitioners, and primary care doctors.
Attendees will engage in dynamic, specialist-led, case-based discussions on managing prevalent adult conditions in primary care. They will also have the opportunity to participate in panel discussions, interactive roundtables, and group sessions designed to foster a comprehensive understanding of adult health conditions and their management approaches. The initiative is co-directed by three distinguished WCM-Q alumni who are now faculty members at the college—Dr. Mahrukh Rizvi, Assistant Professor of medicine (Class of 2011); Dr. Tariq Chukir, Assistant Professor of medicine and Consultant at the National Obesity
Treatment Center at Hamad Medical Corporation (Class of 2015); and Dr. Reshma Bholah, Assistant Professor of pediatrics and Consultant Pediatric Nephrologist at Sidra Medicine (Class of 2011). The conference is coordinated by WCM-Q’s Division of Continuing Professional Development (CPD), which is dedicated to supporting lifelong learning among healthcare professionals.
Reflecting on the significance of the conference, Dr. Mahrukh Rizvi said: “In an ever-evolving healthcare landscape, staying informed about new developments is essential for delivering high-quality patient care. This conference is particularly significant because it is entirely led and delivered by alumni of WCM-Q, showcasing the strength and commitment of our alumni network in contributing to the healthcare landscape. Our alumni’s expertise, combined with their deep understanding of the local and regional context, ensures that the content is highly relevant to the challenges and opportunities faced by primary care practitioners.”
A key highlight of this year’s conference will be a dedicated panel discussion on menopause, recognizing the critical importance of women’s health. The session aims to equip primary care
"THE CONFERENCE FOLLOWS THE SUCCESS OF WCMQ’S INAUGURAL ALUMNI-LED HEALTHCARE CONFERENCE, HELD IN NOVEMBER 2023. THE UPDATES IN PRIMARY CARE CONFERENCE IS PART OF WCM-Q’S WIDER EFFORTS TO ENSURE ITS ALUMNI MAKE VALUABLE CONTRIBUTIONS TO QATAR’S THRIVING HEALTHCARE SECTOR".
providers with the knowledge and skills needed to support women during this significant stage in life. The multidisciplinary panel will include an endocrinologist, psychologist, and gynecologist, offering a comprehensive perspective on the physical, emotional, and psychological challenges associated with menopause.
Elaborating on the importance of the topic, Dr. Rizvi said: “Menopause is a critical aspect of women’s health with far-reaching implications for a large portion of the population. In Qatar, as in many parts of the world, women may hesitate to discuss their struggles with menopause openly, whether with their families or their healthcare providers. Since primary care physicians are often the first point of contact for these patients, they must be well equipped to address the multifaceted challenges associated with menopause. By including this topic in our conference, we aim to foster a deeper understanding of menopause and encourage an open, evidence-based dialogue within the healthcare community.”
Highlighting the conference’s role in bridging the gap between research and practice, Dr. Tariq Chukir said: “Primary care providers are on the front lines of patient care and encounter patients with a wide range of pathologies. Medicine is a rapidly evolving field, making it essential for healthcare professionals to stay up to date with the latest advancements. Conferences like this one are invaluable because
they allow knowledge sharing between experts in various fields, enable the application of the latest research to practices, and ultimately improve patient outcomes. The collaborative nature of this event, which brings together professionals from diverse backgrounds, is particularly beneficial in creating a holistic approach to patient care.”
Emphasizing the overarching goal of the conference, Dr. Reshma Bholah said: “As alumni, we are deeply invested in the continued development of primary care in the region, and this conference is an excellent example of how we can contribute to that goal. Our ultimate aim is to provide primary care providers with the tools they need to excel in their roles, foster collaboration across disciplines, and ensure that the healthcare community in Qatar remains at the forefront of clinical excellence.”
The conference follows the success of WCM-Q’s inaugural alumni-led healthcare conference, held in November 2023. The Updates in Primary Care conference is part of WCM-Q’s wider efforts to ensure its alumni make valuable contributions to Qatar’s thriving healthcare sector.
The conference is accredited in Qatar by Department of Healthcare ProfessionsAccreditation Section (DHP-AS) of the Ministry of Public Health (MoPH) and internationally by the Accreditation Council for Continuing Medical Education (ACCME).
"ATTENDEES WILL ENGAGE IN DYNAMIC, SPECIALIST-LED, CASEBASED DISCUSSIONS ON MANAGING PREVALENT ADULT CONDITIONS IN PRIMARY CARE. THEY WILL ALSO HAVE THE OPPORTUNITY TO PARTICIPATE IN PANEL DISCUSSIONS, INTERACTIVE ROUNDTABLES, AND GROUP SESSIONS DESIGNED TO FOSTER A COMPREHENSIVE UNDERSTANDING OF ADULT HEALTH CONDITIONS AND THEIR MANAGEMENT APPROACHES."
FOR FURTHER INFORMATION OR TO REGISTER TO ATTEND, PLEASE SCAN THE QR CODE
UCLA Health’s new leading-edge theranostics center, using targeted radioactive drugs to treat advanced cancer, is now open.
Offering state-of-the-art facilities and expertise, the 3,000-square-foot Outpatient Theranostics Center in Westwood, part of the UCLA Health Jonsson Comprehensive Cancer
Center, specializes in radiopharmaceutical therapy. It is one of the largest of its kind in the United States, according to Jeremie Calais, MD, PhD, Director of the Ahmanson Translational Theranostics Division of UCLA’s clinical research program. The center recently treated its first patient for metastatic prostate cancer, marking a significant milestone for UCLA Health,
THE TERM THERANOSTICS COMES FROM THE COMBINATION OF THERAPEUTICS AND DIAGNOSTICS.
according to Johannes Czernin, MD, Vice Chair Pharmacology at the David Geffen School of Medicine at UCLA.
The center, which opened Feb. 13, is mostly focused on advanced prostate cancer, but it will also treat patients with thyroid cancer and neuroendocrine tumors. Dr. Calais anticipates that the rapidly growing field of theranostics could eventually expand to include kidney, breast, lung, pancreatic and liver cancers.
The term theranostics comes from the combination of therapeutics and diagnostics.
The treatment, which relies on a therapeutic agent and a diagnostic agent to eliminate the same molecular target, uses the proteins present on tumor cells as anchors for radioactive drugs. This allows doctors to visualize the cancer via a PET scan and then deliver the targeted radioactive medicine to treat it.
Dr. Czernin confirms that the most novel theranostics treatment available for treating metastatic prostate cancer currently has a response rate of 40% to 50%, improving both lifespan and quality of life for patients. This response rate represents a significant success for this treatment method.
In the diagnostic phase, patients receive an injection of a tiny amount of a radiotracer that binds itself to cancer cells, showing the presence of prostate-specific membrane antigen (PSMA)positive lesions. PSMA is overexpressed in prostate cancer. The cancer cells become visible on the PET scan as bright spots.
In the therapeutics phase, eligible patients undergo up to six rounds of treatment with the radioactive drug Pluvicto, which targets and kills those same cancer cells. Treatment efficacy is monitored through imaging, offering immediate results of the therapeutic effects, another breakthrough for this remarkable new method.
People with prostate cancer must have completed or attempted chemotherapy to qualify for treatment with Pluvicto.
Side effects are minimal because the therapy targets the cancer cells and not healthy organs. However, fatigue, nausea, vomiting, bone pain and dry mouth may occur.
Dr. Czernin urges timely referrals for patients not responding to chemotherapy after two or three cycles. Though no stage is too late, he emphasized it is preferable that treatment be administered as early as possible to ensure and expedite the healing process.
Before the center's opening, patients traveled from across the country and around the world for theranostics treatment at UCLA Health. Dr. Czernin expects this trend to continue, noting that the Outpatient Theranostics Center’s large capacity helps ensure short wait times and more efficient service, focusing on patient comfort and providing everything necessary for their treatment and recovery.
The UCLA Health team is committed to patient care, as demonstrated by communicating with referring oncologists throughout treatment. Upon completion, patients are returned to their referring oncologists for ongoing care.
Dr. Czernin added that beyond Pluvicto, the center offers Xofigo for prostate cancer that has spread to the bones, and Lutathera for people with neuroendocrine cancer, often achieving long-term stabilization.
Radioiodine treatment is also available for people with thyroid cancer at intermediate or high risk of recurrence post-surgery.
The first patient treated at the facility for prostate cancer expressed profound gratitude for the care he received, underscoring the positive impact of UCLA Health’s leading-edge theranostics center.
For more information, please visit https://www.uclahealth.org/international-services/ or call +1 310-794-8759
OFFERING STATE-OFTHE-ART FACILITIES AND EXPERTISE, THE 3,000-SQUAREFOOT OUTPATIENT THERANOSTICS CENTER IN WESTWOOD, PART OF THE UCLA HEALTH JONSSON COMPREHENSIVE CANCER CENTER, SPECIALIZES IN RADIOPHARMACEUTICAL THERAPY.
Dr. Lyor Hanan is a highly esteemed Plastic and Reconstructive Surgeon, renowned for his exceptional breast and facial surgery skills. Now based in Dubai at Beauté Concept by CSHP, Dr. Lyor Hanan is leading the way in innovative breast beautification techniques, particularly with his expertise in the Mia® technique. This groundbreaking approach is done under local anesthesia and results in a small incision under the armpit. It has a quick recovery time, low discomfort, making it a revolutionary option for consumers seeking minimally invasive breast enhancement.
Dr. Lyor Hanan’s comprehensive training in Paris, where he completed his medical and surgical studies at the prestigious Faculty of Medicine BichatLariboisière, has equipped him with a deep understanding of aesthetic and reconstructive breast surgery. His expertise extends to breast reduction, lifting, and post-mastectomy reconstruction, where his meticulous attention to detail ensures natural and harmonious results.
Dedicated to staying at the forefront of his field, Dr. Lyor Hanan regularly participates in and lectures at international plastic surgery conferences. His commitment to innovation and excellence in breast surgery makes him a sought-after expert. He provides his consumers with the highest-quality care and the latest surgical advancements.
‘Hospitals’ magazine recently met Dr. Lyor Hanan to discuss the groundbreaking Mia® technique for breast harmonization.
Could you share your journey to becoming a plastic surgeon and give us an insight into your daily responsibilities?
I'm originally from Paris, France, where I completed my medical studies and plastic surgery residency. I've been practicing as a plastic surgeon for seven years now. In France, I focused on reconstructive surgery (particularly after breast and skin cancer) and aesthetic surgery (breast and facial surgery).
I am now based full-time in Dubai, specializing exclusively in aesthetic plastic surgery at Beauté Concept by CSHP in Jumeirah. I moved at the beginning of this year, drawn by the opportunity to work at a leading hospital in Dubai, as well as the appealing lifestyle and
climate, which made it the perfect choice for me and my family.
What are the most rewarding and challenging aspects of your work as a breast surgeon?
One of the most rewarding aspects of plastic surgery is witnessing the transformative impact it can have on a consumer's self-esteem and quality of life.
For instance, after a breast reduction, women often express newfound confidence and comfort in their bodies, relieved from the physical and emotional burdens of large breasts. Seeing consumers embrace their appearance and regain their sense of self-worth is deeply
ONE OF THE MOST REWARDING ASPECTS OF PLASTIC SURGERY IS WITNESSING THE TRANSFORMATIVE IMPACT IT CAN HAVE ON A CONSUMER'S SELF-ESTEEM AND QUALITY OF LIFE.
gratifying, knowing that I’ve played a role in improving their self-esteem.
Can you explain how the Mia® technique works?
Mia® technique offers a significant advancement in breast surgery. Unlike traditional methods, which require larger incisions and general anesthesia, Mia® results in a small incision under the armpit and is performed under local anesthesia. This minimally invasive approach not only minimizes scarring but also reduces discomfort and recovery time.
A key advantage of Mia® technique is its preservation of breast tissue. Instead of cutting into the breast tissue to create a pocket for the implant, Mia® procedure employs a balloon that is inflated to gently expand the tissue. This approach results in a more natural-looking outcome and potentially reduces the risk of complications associated with cutting into the breast tissue.
Another notable benefit of Mia® technique is the shorter surgery time and faster recovery period. The procedure typically takes only 15 minutes, allowing the consumer to return home within an hour. This significantly reduces the downtime and discomfort associated with traditional breast augmentation. In conclusion, Mia® technique represents a significant advancement in breast enhancement. Its benefits include smaller incisions, local anesthesia, preservation of breast tissue, shorter surgery time, and faster recovery.
What materials are used in Mia® implants, and how do they differ from traditional breast implants?
Mia® implants are a revolutionary advancement in breast enhancement, featuring a unique biocompatible silicone gel that is exceptionally soft and pliable. Unlike traditional implants, which often have a round shape and a firmer texture, Mia® implants are diamond-shaped and offer a more subtle enhancement. This innovative gel implant is designed to seamlessly integrate with the surrounding breast tissue, providing a more harmonious and natural result. The softness and flexibility of Mia® implants
allow them to conform more naturally to the shape of the breast, resulting in a more aesthetically pleasing outcome. Additionally, the diamond shape of Mia® implants can help to create a more lifted and projected appearance, without sacrificing the natural contours of the breast. Mia® implants offer a significant improvement over traditional breast implants in terms of both feel and appearance. Their unique silicone gel composition and diamond shape contribute to a more natural and aesthetically pleasing result, making them an excellent choice for women seeking breast harmonization.
What is the recovery process like after the Mia® procedure, and how soon can consumers return to normal activities?
The recovery process after Mia® procedure is typically very quick, with many consumers returning to their normal daily activities within two to three days. While some discomfort may be experienced for up to a week, most consumers report minimal pain after just a few days. Light exercise can usually be resumed after three weeks, and it's recommended to wear a supportive bra for two to three weeks post-surgery.
How do you ensure personalized care and satisfaction throughout the Mia® procedure, from consultation to postprocedure care?
To ensure the highest level of care and support throughout the Mia® procedure and recovery, I maintain close communication with the consumer. I provide each woman with my personal contact information so she can reach out with any questions or concerns at any time. I also conduct regular follow-up appointments at seven days, one month, six months, and one year after surgery.
This ongoing care allows me to monitor the healing process, promptly address any issues, and ensure that each patient is fully satisfied with her results.
Who is an ideal candidate for the Mia® procedure?
The ideal candidate for Mia® procedure is a
ANOTHER NOTABLE BENEFIT OF MIA® TECHNIQUE IS THE SHORTER SURGERY TIME AND FASTER RECOVERY PERIOD. THE PROCEDURE TYPICALLY TAKES ONLY 15 MINUTES, ALLOWING THE CONSUMER TO RETURN HOME WITHIN AN HOUR. THIS SIGNIFICANTLY REDUCES THE DOWNTIME AND DISCOMFORT ASSOCIATED WITH TRADITIONAL BREAST AUGMENTATION.
woman with smaller breasts who desires a modest enhancement of one or two cup sizes. This procedure is particularly well suited for individuals who are satisfied with the overall shape of their breasts but seek a subtle enhancement to achieve breast harmonization. Consumers who desire a natural-looking result, with a slight increase in volume and cleavage, without an overly exaggerated appearance, are ideal candidates for the Mia® procedure. Conversely, women with larger breasts or those seeking a significant increase in cup size may benefit more from traditional breast augmentation. Additionally, Mia® is a good option for women who prefer a less invasive procedure with a shorter recovery time.
Does breast sensation change after the Mia® procedure?
One of the most notable benefits is the preservation of natural sensation and function in the breast tissue. Unlike some traditional procedures that can interfere with nipple sensation or lactation, Mia® is designed to minimize disruption to these vital aspects of breast function. Following Mia® procedure, some consumers may experience temporary hypersensitivity in the nipple area. This sensation is typically mild and resolves within a few weeks. Additionally, there may be a slight burning sensation around the scar for the first two to three weeks. However, over time, the implant will integrate seamlessly with the breast tissue, and any hypersensitivity will subside.
Are there any concerns for consumers who wish to have children or breastfeed after undergoing the Mia® procedure?
If a woman is planning to have children shortly, it's best to postpone it. Hormonal fluctuations during pregnancy and breastfeeding can affect breast shape and size, potentially impacting the outcome of the procedure.
While it's generally safe to have breast augmentation with implants after breastfeeding, it's advisable to wait at least six months following the completion of breastfeeding to allow for any hormonal changes to stabilize.
This will help ensure that the desired results are achieved and that the implants are placed in the most optimal position. It's important to consult with your plastic surgeon to discuss your circumstances and determine the best timing for breast augmentation based on personal goals and medical history.
Is it safe for women to have a mammography before and after the Mia® procedure?
I strongly recommend that women undergo mammograms before the Mia® procedure. This is essential for early detection of any breast abnormalities and to monitor the long-term health of the breast tissue.
I typically prescribe either mammograms or ultrasound every two years for my patients. The flexibility of breast implants does not interfere with the accuracy of mammograms.
Mr.
At the recent Africa Health ExCon, eHealth, a leading figure in the digital health sector, showcased its advanced cloud infrastructure and smart solutions, emphasizing the transformative potential of technology in healthcare. A significant highlight of the event was the partnership between eHealth and Doctory, aimed at developing a pioneering smart clinic model. By combining eHealth's digital expertise with Doctory's healthcare insights, this collaboration seeks to enhance healthcare efficiency and position the region as a leader in health tourism.
‘Hospitals’ magazine had the opportunity to interview Mr. Hassan Elsokkary, CEO of eHealth, who shared insights into the innovative solutions eHealth is bringing to the healthcare industry and the strategic goals of the partnership with Doctory.
Could you elaborate on eHealth's overarching vision? How does the company plan to leverage its position to drive this vision forward?
eHealth's overarching vision is to revolutionize healthcare delivery through comprehensive digital transformation. Our mission is to create a seamlessly integrated ecosystem that enhances accessibility, efficiency, and quality of care across both public and private sectors.
To drive this vision forward, we are leveraging our position as a key player in the digital health space by forming strategic partnerships with governmental bodies, private healthcare providers, and industry innovators. Our role in managing the digital infrastructure for the universal health insurance system showcases our capacity to deliver and maintain large-scale, impactful solutions. Simultaneously, we are actively collaborating with private healthcare entities to ensure our solutions cater to diverse market needs, fostering innovation across the entire healthcare landscape.
THIS PARTNERSHIP AIMS TO CREATE A BLUEPRINT FOR MODERN HEALTHCARE FACILITIES THAT CAN BE SCALED AND REPLICATED, ULTIMATELY CONTRIBUTING TO THE NATIONAL HEALTH TOURISM STRATEGY AND SETTING NEW STANDARDS FOR PATIENT CARE AND EXPERIENCE.
Can you discuss the creative and innovative solutions eHealth presented during the Africa Health ExCon? What were the primary objectives of eHealth's participation?
At the Africa Health ExCon, our primary objective was to demonstrate eHealth's innovative solutions that are transforming the healthcare landscape for both public and private stakeholders. We showcased our state-of-theart cloud infrastructure and smart solutions designed to create a more connected and efficient healthcare ecosystem, bridging the gap between public health initiatives and private sector capabilities.
Our participation was focused on highlighting how these technologies can address critical challenges in healthcare delivery, particularly in emerging markets, while offering compelling value propositions for private healthcare providers. We emphasized how our solutions can improve patient outcomes, streamline operations for healthcare providers across sectors, and support the overall digitalization of health services.
How do you believe the smart clinic concept can contribute to the development of medical tourism in the region?
The smart clinic concept holds significant
potential to enhance medical tourism in the region. By integrating advanced technologies and streamlined processes, smart clinics can offer world-class healthcare experiences that attract international patients. These facilities provide seamless, digitally-enabled services, from pre-arrival consultations to post-treatment follow-ups, making the entire medical journey more accessible and appealing to global health consumers. The data-driven approach of smart clinics allows for personalized care and improved outcomes, further boosting the region's reputation as a medical tourism destination. By connecting innovative solutions with healthcare providers, we are building a robust infrastructure that can support and expand the medical tourism sector.
How did the collaboration between eHealth and Doctory come about? What were the shared objectives for developing the smart clinic concept?
The collaboration between eHealth and Doctory was born out of a shared vision to advance healthcare through technology, with a particular focus on enhancing national health tourism. Both entities recognized the potential of combining eHealth's digital expertise with Doctory's healthcare insights to create a truly innovative smart clinic concept.
THE SMART CLINIC CONCEPT HOLDS SIGNIFICANT POTENTIAL TO ENHANCE MEDICAL TOURISM IN THE REGION. BY INTEGRATING ADVANCED TECHNOLOGIES AND STREAMLINED PROCESSES, SMART CLINICS CAN OFFER WORLD-CLASS HEALTHCARE EXPERIENCES THAT ATTRACT INTERNATIONAL PATIENTS.
Our joint objective is to develop a model that not only improves healthcare delivery efficiency but also positions our region as a leader in health tourism.
This partnership aims to create a blueprint for modern healthcare facilities that can be scaled and replicated, ultimately contributing to the national health tourism strategy and setting new standards for patient care and experience.
What role does the smart clinic play in activating digital health in the region?
The smart clinic plays a pivotal role in advancing digital health in the region by serving as a proof of concept for integrated, technology-
driven healthcare. It demonstrates how various digital health technologies – from electronic health records to telemedicine and AI-assisted diagnostics – can work together in a realworld setting. This model clinic acts as both an inspiration and a learning platform for other healthcare providers, encouraging broader adoption of digital health solutions. Moreover, it serves as a catalyst for further innovation in the sector, attracting investments and talent to the digital health ecosystem. By showcasing the tangible benefits of digital health integration, the smart clinic concept is accelerating the region's journey towards a fully digitalized and interconnected healthcare system.
OUR JOINT OBJECTIVE IS TO DEVELOP A MODEL THAT NOT ONLY IMPROVES HEALTHCARE DELIVERY EFFICIENCY BUT ALSO POSITIONS OUR REGION AS A LEADER IN HEALTH TOURISM
Clemenceau Medical Center, Beirut (CMC) continues to prioritize top-tier healthcare for its patients by equipping its Cardiac Imaging Department with cutting-edge technology. These advancements enable precise and prompt diagnosis of heart diseases, assisting physicians in making timely treatment decisions. This commitment solidifies Clemenceau Medical Center's leadership in diagnosing and treating cardiovascular conditions in Lebanon and the wider region. In an exclusive interview with "Hospitals magazine, Dr. Mohamad Mansour, Director of the Non-Invasive Cardiology Department at Clemenceau Medical Center in Beirut, discussed the latest advancements in cardiac imaging and the center's role as a premier destination for cardiovascular care.
Could you please provide more details on the latest developments in Cardiac CT scanning at Clemenceau Medical Center in Beirut?
Our Cardiac Imaging Department has recently undergone significant upgrades, most notably with the acquisition of the Revolution APEX Cardiac CT scan. This state-of-the-art device is among the most advanced globally, and we are proud to be the first facility in the Middle East to offer this technology to our patients.
One of the key benefits of this new technology is the substantial reduction in radiation exposure, making the imaging process safer, particularly for patients who require frequent scans. Additionally, advanced technology allows us to use less contrast material to achieve high-quality images, which is especially beneficial for patients with kidney conditions.
The Revolution APEX also features Single Beat Acquisition technology, enabling us to capture high-quality images even when a patient's heart rate is elevated. This is a significant improvement over older devices, which required us to wait until the patient’s heart rate was between 50 and 60 beats per minute to perform a CT scan. The advancements in speed and sensitivity mean that we can now obtain clear and sharp images even with a faster heart rate.
Moreover, we are now offering advanced FFR CT (Fractional Flow Reserve CT) technology, the first of its kind in Lebanon and the Middle East. This non-invasive technique allows us to accurately assess blood flow in the coronary arteries, aiding in the diagnosis of coronary artery diseases and guiding appropriate treatment decisions.
In summary, these technological advancements allow us to provide more accurate and precise imaging while reducing the risks associated with traditional scans. This enables us to offer our patients safer diagnostic services without resorting to invasive procedures unless necessary.
The integration of artificial intelligence (AI) in cardiac CT scanning has significantly enhanced diagnostic efficiency. AI-powered algorithms enable the rapid and accurate processing of images, allowing us to examine more patients in a shorter amount of time while still delivering precise results.
AI also automates the analysis of images, identifying coronary arteries and other critical structures, which saves physicians a considerable amount of time and effort. This allows doctors to focus on more complex aspects of diagnosis.
OUR CARDIAC IMAGING DEPARTMENT HAS RECENTLY UNDERGONE SIGNIFICANT UPGRADES, MOST NOTABLY WITH THE ACQUISITION OF THE REVOLUTION APEX CARDIAC CT SCAN. THIS STATEOF-THE-ART DEVICE IS AMONG THE MOST ADVANCED GLOBALLY, AND WE ARE PROUD TO BE THE FIRST FACILITY IN THE MIDDLE EAST TO OFFER THIS TECHNOLOGY TO OUR PATIENTS.
However, the physician's role remains essential in the diagnostic process, as they review the AI-generated results and provide the final diagnosis.
What diseases can be diagnosed using this advanced technology?
This cutting-edge imaging technology allows us to diagnose a wide range of conditions affecting the heart, blood vessels, and surrounding organs. It is particularly effective in detecting coronary artery blockages, assessing heart muscle and valve stucture, examining the aorta and pulmonary arteries, and evaluating the pericardium. Additionally, we can use it to investigate nearby organs, such as the lungs and larynx.
The Cardiac MRI technology in the Radiology Department at CMC has been upgraded. Can you tell us more about this?
Cardiac MRI is indeed a valuable addition to our imaging capabilities, and it has seen significant improvements with the integration of AIR™ Recon DL technology into our 3 Tesla MRI machine. This upgrade has greatly enhanced image quality, reduced scanning time, and enabled us to use advanced techniques like T1T2 mapping.
These advancements allow for accurate diagnosis of heart muscle diseases, such as fibrosis and myocardial edema. The new CVI42 software, supported by AI, streamlines the analysis process and improves the accuracy of our diagnostic results.
Echocardiography is a critical tool in cardiology clinics. What advancements have been made in this area?
We are excited to offer the latest in 3D echocardiography with the VIVID E95 Ultra Edition. This advanced device provides highresolution 3D images, allowing for incredibly precise diagnoses of heart conditions. Echocardiography is an essential diagnostic tool in cardiology, as it provides detailed images of the heart, valves, and arteries. This information is crucial for diagnosing various cardiac conditions and determining the appropriate treatment, whether that involves medical
management or surgical intervention. With this technology, Clemenceau Medical Center in Beirut can provide diagnostic services that are on par with those offered at leading centers worldwide.
How is the appropriate type of medical imaging determined for a patient?
The choice of imaging technique depends on the specific heart condition being investigated. Generally, cardiac MRI is used to study heart function and diagnose diseases affecting the heart muscle, valves, and pericardium, including congenital defects. On the other hand, cardiac CT is primarily used to assess the anatomy of the heart and coronary arteries, which are the vessels supplying the heart muscle. This technology also plays a significant role in providing precise measurements for transcatheter valve replacement procedures.
CARDIAC MRI IS INDEED A VALUABLE ADDITION TO OUR IMAGING CAPABILITIES, AND IT HAS SEEN SIGNIFICANT IMPROVEMENTS WITH THE INTEGRATION OF AIR™ RECON DL TECHNOLOGY INTO OUR 3 TESLA MRI MACHINE.
Motion-Preserving Surgical Technique for Adolescent Kyphosis: Tethering / Band Tensioning
Kyphosis, commonly known as a hunchback, is a condition characterized by an excessive forward curvature of the spine. Adolescent kyphosis, which typically manifests during puberty, can significantly impede normal growth and development in children, necessitating early therapeutic intervention. In recent years, tethering (band-tensioning) surgery—a minimally invasive, motion-preserving procedure that offers complete recovery—has emerged as a leading option for patients requiring surgical intervention. The "Posterior Vertebral Tethering" technique, developed by Prof. Dr. Mehmet Aydoğan, the Head of the Advanced Spine Center at Memorial Şişli Hospital, and recognized in medical literature worldwide, allows patients to resume their school and social lives in a short time without any loss of movement, and even to continue engaging in sports and dance at a professional level.
Adolescent kyphosis is a progressive spinal disorder that manifests as increasing hunchback in children aged 10 to 19 years. The prevalence of the condition ranges between 4-8%. Although genetic factors are thought to
play a role in its onset, the exact cause remains unclear. The pathophysiology of kyphosis involves a slowed growth in the anterior aspect of the vertebral column while growth in the posterior aspect continues, resulting in the formation of a spinal curvature. As the condition progresses, an increase in curvatures in the lumbar and cervical regions may also occur simultaneously, disrupting the body’s overall balance and significantly diminishing quality of life, causing back and neck pain. In advanced cases, kyphosis may necessitate lumbar-cervical surgeries and potentially lead to shortness of breath and respiratory difficulties. Particularly in children and adolescents, the aesthetic concerns caused by kyphosis can also lead to various psychological and behavioral issues.
It is crucial for children with noticeable spinal curvature to be examined by a physician at an early stage. The degrees of kyphosis are determined by calculating the curvature of the spine. While the upper limit for spinal curvature is 50 degrees, surgical intervention is considered for kyphosis patients when the curvature exceeds 70 degrees, as the condition can increasingly impair quality of life. The goal of kyphosis surgery is to correct the spinal deformity, achieving a functional, pain-free, and aesthetically pleasing spine. This allows the child to continue living a healthy life.
PROF. DR. MEHMET AYDOĞAN HAS BEEN CONDUCTING SCIENTIFIC RESEARCH IN THE FIELD OF SPINE SURGERY FOR OVER 20 YEARS AT PRESTIGIOUS HOSPITALS IN TURKEY AS WELL AS UCLA (THE UNIVERSITY OF CALIFORNIA, LOS ANGELES).
The conventional surgical management of kyphosis involves the correction of spinal curvature through the application of pedicle screws and rods, culminating in the fusion of the involved vertebrae. Although this approach restores physiological spinal alignment, it inevitably results in the loss of movement between the vertebrae, which adversely affects not only the patients' range of motion but their overall quality of life. This has led to the development of new treatment approaches aimed at supporting a more comfortable growth process for patients.
Prof. Dr. Mehmet Aydoğan, the Head of the Advanced Spine Center at Memorial Şişli Hospital, has developed a method for treating kyphosis inspired by his experience with scoliosis surgeries. The technique, known as "Posterior Vertebral Tethering," allows for the treatment of kyphosis without fusing the vertebrae, thereby preserving intervertebral movement. As a result, children who undergo kyphosis treatment using this method can continue their lives without loss of mobility. Furthermore, those who wish to pursue careers as professional athletes or dancers are not adversely affected by having undergone kyphosis surgery.
• Tethering surgery supports the child's growth process and does not hinder it.
• It preserves the mobility of the spine, allowing children to continue engaging in professional sports and dance activities.
• The operation is performed using a minimally invasive technique with small incisions, leaving no visible scars.
• The risk of bleeding and infection is minimal.
• The recovery time is significantly reduced, enabling children to return to school and their daily activities quickly.
Prof. Dr. Mehmet Aydoğan has been conducting scientific research in the field of spine surgery for over 20 years at prestigious hospitals in Turkey as well as UCLA (the University of California, Los Angeles).
He meticulously followed the clinical and radiological outcomes of the first 10 patients treated with the "Posterior Vertebral Tethering" method over an average of three years. The results of his work were published in the European Spine Journal, one of the most respected journals in orthopedics and traumatology, and the official publication of the European Spine Society, announcing the outcomes of his method to the scientific community.
This groundbreaking technique, which has been recognized as a major advancement in the field of spine surgery, has been wellreceived in the literature and has garnered substantial interest from specialists worldwide. The possibility for children with kyphosis in other regions to be treated with the "posterior vertebral tethering" method, preserving spinal flexibility and restoring their health, is both a source of pride and joy for us.
PROF. DR. MEHMET AYDOĞAN, THE HEAD OF THE ADVANCED SPINE CENTER AT MEMORIAL ŞIŞLI HOSPITAL, HAS DEVELOPED A METHOD FOR TREATING KYPHOSIS INSPIRED BY HIS EXPERIENCE WITH SCOLIOSIS SURGERIES. THE TECHNIQUE, KNOWN AS "POSTERIOR VERTEBRAL TETHERING," ALLOWS FOR THE TREATMENT OF KYPHOSIS WITHOUT FUSING THE VERTEBRAE, THEREBY PRESERVING INTERVERTEBRAL MOVEMENT. AS A RESULT, CHILDREN WHO UNDERGO KYPHOSIS TREATMENT USING THIS METHOD CAN CONTINUE THEIR LIVES WITHOUT LOSS OF MOBILITY.
Cinfa is a Spanish pharmaceutical laboratory with 55 years of experience and more than 2,200 professionals. Their main objective is to provide top-notch health solutions through accessible and high-quality products, which has earned them a prominent place in the national and international pharmaceutical market. In 2023, Cinfa's turnover reached 760 million dollars.
As a 100% Spanish-owned enterprise, Cinfa is dedicated to improving healthcare accessibility with the highest quality standards. In its home country, it dominates the pharmaceutical market, leading both in terms of product value and the number of treatments dispensed in retail pharmacies.
Cinfa's mission extends far beyond Spain’s boarders. With a presence in more
than 100 countries, it works to ensure that its healthcare solutions are accessible to people around the world.
In addition, the laboratory is committed to innovation, it has an R+D team with more than 100 people dedicated to the development of advanced solutions for healthcare.
Over the past decade, it has invested a total of $480 million in research and development and collaborates with more than 70 universities and research centers around the world, fostering an environment of continuous improvement and advancement.
It has a wide range of products, including prescription medicines, consumer health care (HCC) solutions, mobility and personal
CINFA'S GLOBAL PRESENCE EXTENDS TO REGIONS SUCH AS THE MIDDLE EAST, CENTRAL AMERICA AND SOUTHEAST ASIA. IN THE MIDDLE EAST, CINFA HAS MADE A SIGNIFICANT IMPACT, COLLABORATING WITH MORE THAN 8,500 MEDICAL CENTERS AND PHARMACIES IN SAUDI ARABIA, QATAR, THE UNITED ARAB EMIRATES AND KUWAIT.
care products. This diversity allows it to meet a wide range of healthcare needs, further solidifying its position as a trusted partner in healthcare. Always operating under the strict regulatory frameworks of bodies such as the FDA and the European Medicines Agency, thus guaranteeing that its products consistently meet the highest quality standards.
Global reach with a regional focus
Cinfa's global presence extends to regions such as the Middle East, Central America and Southeast Asia. In the Middle East, Cinfa has made a significant impact, collaborating with more than 8,500 medical centers and pharmacies in Saudi Arabia, Qatar, the United Arab Emirates and Kuwait.
Mikel Zumalabe, International Marketing Manager at Cinfa Group, has highlighted that “10 years ago, Cinfa started its activity in the region initially focusing on the United Arab Emirates market. Later it has expanded its reach to other countries such as KSA, Qat and KWT with the intention of continuing to expand”.
Its international spokesperson has added that, "Cinfa’s main goal is to expand to new countries in the region, such as Bahrain, and to launch new and innovative molecules within the Anatomical Therapeutic Chemical (ATC) classification system in which it is present today, as well as to venture into new ATCs that have a great impact on the region, such as diabetes."
Cardiology is one of the main therapeutic areas in the Middle East
Cinfa has a wide range of products in the cardiovascular therapeutic area that cover several diseases such as hypercholesterolemia, hypertension or heart failure, as well as their role in the prevention of cardiovascular diseases.
As its medical spokesperson, Dr. Alicia López de Ocáriz, has highlighted, “Cinfa continues to develop medicines in this area, for example, for heart failure. Everything we can do to improve the heart function of these patients will improve their quality of life and reduce the number of hospitalizations that represent the greatest expense associated with this disease”.
Currently, Cinfa’s research and development team is also focused on anticoagulant medicines. Specifically, it is working on two types, more effective and safer: direct thrombin inhibitors (DTIs) and direct factor Xa inhibitors.
In terms of where cardiology should continue to advance, Dr. Alicia López de Ocáriz has highlighted that “there is currently a need to improve current therapies, which are largely palliative therapies, to also address massive tissue destruction after myocardial infarction. To this end, we need to continue to work on strengthening the efforts dedicated to myocardial regeneration”.
DR. ALICIA LÓPEZ DE OCÁRIZ, CORPORATE MEDICAL DIRECTOR AT CINFA GROUP: "OUR MAIN CHALLENGE IS TO CONTINUE OFFERING PATIENTS MEDICINES THAT HELP IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES, WHICH ARE THE LEADING CAUSE OF DEATH IN THE WORLD".
University of Chicago Medicine patient Alla Pinzour was the first person in Illinois, and one of the first people in the country, to receive commercially approved TIL therapy for treatment of her advanced melanoma
‘A one-and-done treatment’: UChicago Medicine among the first in the U.S. to use TIL therapy for advanced skin cancer
For 15 years, Alla Pinzour traveled the country seeking treatments for her advanced melanoma. Some would bring temporary remission, but her skin cancer always returned.
“Surgeries, chemo, radiation — you name it, I had it done,” she said. “Nothing seemed to work.”
By early 2024, Pinzour’s skin cancer had spread to other places in her body, including her lungs and stomach. As her health deteriorated, the only thing doctors could do was re-try treatments she’d already tried.
That’s when Pinzour’s oncologist told her about a groundbreaking new melanoma treatment that would soon be offered at the University of Chicago Medicine.
The use of tumor-infiltrating lymphocyte therapy, also known as TIL therapy, boosts a person’s cancer-fighting cells to help their own immune system kill the cancer.
In mid-February 2024, the Food and Drug Administration approved the use of TIL therapy for advanced melanoma. Weeks later, Pinzour became the first person in Illinois — and one of the first in the country — to have the commercially approved treatment.
“We did a lot of planning and training with the research team and the operating room nurses and staff, so as soon as the FDA said ‘Go,’ we were the first ones to do it,” said Pinzour’s surgeon, UChicago Medicine surgical oncologist Mecker G. Möller, MD.
The results have been dramatic. The cancerous tumors under Pinzour’s skin started to shrink soon after. Her latest scan, in July, showed even more positive clinical response, Möller said.
“If it continues to work, this might be the only treatment she ever needs,” said UChicago Medicine oncologist Daniel Olson, MD, who helped administer Pinzour’s TIL therapy. “A
Mecker G. Möller, MD Professor of Surgery. Director, Regional Therapies Program. Director, Surgical Oncology Fellowship Program
Mecker G. Möller, MD, is a Professor of Surgery and Director of UChicago Medicine's Regional Therapies Program and Surgical Oncology Fellowship Program.
one-time infusion of these cells can sometimes drive melanoma into remission.”
Pinzour, now 50, said she feels great. She plans to return to her catering business and may take a celebratory vacation with her husband in Europe.
“I’ve been waiting for this for many, many years,” said Pinzour, a mother of two who lives in north suburban Hawthorn Woods. “I would have gone anywhere in the world to get this, but I was able to get it right here in Chicago.”
UChicago Medicine doctors have since used TIL therapy on other patients with advanced melanoma, and more are scheduled in the coming months.
“TIL therapy gives patients hope when there wasn’t any before,” Olson said. “We’re the only people doing it in Chicago right now. It’s a really complicated therapy that takes a well-oiled process to make it happen, but we’re doing it.”
TIL therapy was developed in the 1990s by the National Cancer Institute, but it’s a complex therapy that took decades to fine-tune, Olson said. It involves a two-step process. First, the patient’s own cancer-fighting T cells (tumor-infiltrating lymphocytes, or TILs) are surgically removed from their tumor. The cells are sent to a lab, where they’re strengthened and multiplied into the billions.
Then, the supercharged TILs are frozen and returned to the hospital. After being carefully defrosted, the cells are returned to the body through an IV.
The excessive number of TILs, far more than typically found in a person’s body, helps provide the power to destroy the tumor.
“It’s a one-and-done treatment,” Olson said.
Patients will see their oncologist once or twice a week for the first month to monitor blood counts and check for complications. At three months, they will receive an imaging scan to see if the tumors are shrinking.
Despite seeing positive results in his patients, Olson notes that TIL therapy doesn’t work for everyone. Only one-third to one-half of all patients will see a benefit, he said, and most advanced melanoma patients will not get long-term remission.
“The clinical trials have already been run, so we know our expectations going into it,” he said. “Still, for patients with melanoma who don’t respond to the standard therapy, it’s the best thing out there.”
That’s good news for patients like Pinzour, who in 2009 noticed a tiny mole on the bottom of her leg. When it started to grow, she saw a doctor who confirmed it was melanoma.
At the time, there was only one available drug to treat melanoma and Pinzour didn’t tolerate it well. But she kept taking it, and her cancer went into remission until 2015, when the drug was no longer effective. She’s been tirelessly fighting the disease ever since.
When Pinzour heard about TIL therapy, she immediately reached out to UChicago Medicine, whose medical oncologists and scientists at the David and Etta Jonas Center for Cellular Therapy continue to study the wider potential of TIL therapy for tumor types, including cervical cancer.
“TIL therapy has changed the landscape of how we treat melanoma,” said Möller, who also directs the Regional Cancer Therapies program.
UChicago Medicine’s TIL therapy team includes Olson; Möller; Surgical Oncologist and Vice Chair of Global Surgery, J. Michael Millis, MD; Surgical Oncologist Thomas F. Gajewski, MD, PhD; Director of the Cell Therapy Program, Mylove Mortel, MSPH, RN, OCN; Endocrine and Neuroendocrine Surgeon Xavier M. Keutgen, MD; Director of Surgical Cancer Quality Ryan Merkow, MD, MS; Director of Melanoma Surgery Cristina O’Donoghue, MD; and Director of the Hematopoietic Stem Cell Transplantation Program, Michael R. Bishop, MD.
Daniel Olson, MD, is a highly skilled oncologist who specializes in diagnosing and treating skin cancers and sarcomas. He is an expert in advanced medical oncology treatment methods, including new cellular therapies such as tumor-infiltrating lymphocyte (TIL) therapy for melanoma.
The field of mental health is witnessing tremendous advancements, thanks to technological progress, particularly the integration of artificial intelligence (AI), which is playing an increasingly crucial role in helping psychiatrists provide better and more efficient mental healthcare.
AI has revolutionized psychiatric treatment by enhancing diagnostic accuracy, improving therapeutic outcomes, and optimizing patient care. It's important to emphasize that AI cannot replace the expertise of a specialized psychiatrist; rather, it serves as a component of a comprehensive treatment approach that includes essential human interaction. Integrating AI with mental healthcare
enables psychiatrists to offer a more personalized and holistic approach to managing psychological issues.
AI also plays a significant role in clinical research, aiding in the discovery of risk factors and the underlying mechanisms of anxiety disorders. AI systems can analyze patients' behavioral and physiological data to accurately diagnose various mental health conditions and anxiety disorders. They can also develop personalized treatment programs for patients, including cognitive-behavioral therapy and mindfulness training
AI opens new horizons for the treatment of
IT'S IMPORTANT TO EMPHASIZE THAT AI CANNOT REPLACE THE EXPERTISE OF A SPECIALIZED PSYCHIATRIST; RATHER, IT SERVES AS A COMPONENT OF A COMPREHENSIVE TREATMENT APPROACH THAT INCLUDES ESSENTIAL HUMAN INTERACTION
mental health conditions by providing tailored support and precise data analysis. It is a powerful tool in mental healthcare, capable of detecting early signs of mental illnesses and delivering personalized treatment plans, leading to significantly improved therapeutic outcomes.
Thanks to AI, it is now possible to assist individuals with mental health issues more effectively and accurately through intelligent software programs that analyze data and offer appropriate solutions for each case.
AI can predict mental health disorders early by analyzing extensive health data, such as medical and genetic records, to identify individuals at risk. AI algorithms are adept at linking various data patterns to determine factors contributing to mental health disorders. By analyzing vast amounts of data, AI contributes to a deeper understanding of mental disorders and the development of personalized treatments. It can uncover complex relationships between different factors affecting mental health.
AI plays a vital role in enhancing the psychotherapy experience. Through mobile applications, patients can easily track their symptoms and mood, enabling psychiatrists to better understand their condition and adjust treatment plans accordingly. This ensures patients receive appropriate care at the right time and reduces the risk of relapses.
Psychiatrists and mental health professionals have leveraged AI systems to enhance the care of patients with anxiety disorders in several ways. AI systems can analyze patient data (medical records, behavioral data, physiological data) to identify patterns and signs of specific anxiety disorders, leading to faster and more accurate diagnoses.
Using data and analytics, these systems can suggest personalized treatment plans for each patient, including coordinating different therapies such as cognitive-behavioral therapy, pharmacotherapy, and appropriate medication dosages. Psychiatrists can also monitor and manage patients' conditions through AI-
powered smartphone applications, allowing continuous patient monitoring and reminders for therapeutic practices, encouraging adherence to treatment.
Effectively integrating AI into the care of anxiety disorders can improve diagnosis and treatment and enhance patient outcomes. AI systems serve as a supportive tool in traditional psychiatric care rather than replacing it. This ensures that psychiatrists can utilize the strengths of both AI and human expertise to improve diagnosis and treatment. Successfully incorporating AI into psychiatric practice requires balancing technology and the human element to achieve the best outcomes for patients.
There are fundamental ethical guidelines that psychiatrists must consider when using AI in treating their patients:
1. Maintaining Confidentiality and Privacy: Ensuring the security of sensitive medical data and not violating patient privacy when using AI technologies.
2. Transparency in Technology Use: Clearly informing patients about any AI technologies used in their treatment and obtaining their prior consent.
3. Ensuring Accuracy and Reliability: Verifying that the AI models used are free from errors that could affect diagnostic and therapeutic accuracy.
4. Preserving Human Interaction: Balancing the use of AI with maintaining the human interaction and empathy essential in psychotherapy.
5. Adhering to Professional Standards: Ensuring that the use of AI aligns with the ethical and legal standards of psychiatric practice.
6. Continuous Training and Development: To use AI technologies effectively and safely, psychiatrists must stay updated with ongoing advancements in the field.
7. Defining Responsibilities: Establishing clear guidelines on the responsibilities associated with using AI in psychotherapy and determining accountability in case of errors.
AI PLAYS A VITAL ROLE IN ENHANCING THE PSYCHOTHERAPY EXPERIENCE. THROUGH MOBILE APPLICATIONS, PATIENTS CAN EASILY TRACK THEIR SYMPTOMS AND MOOD, ENABLING PSYCHIATRISTS TO BETTER UNDERSTAND THEIR CONDITION AND ADJUST TREATMENT PLANS ACCORDINGLY. THIS ENSURES PATIENTS RECEIVE APPROPRIATE CARE AT THE RIGHT TIME AND REDUCES THE RISK OF RELAPSES.
Dr. Osman Ortash, Consultant in Obstetrics & Gynecology
Uterine prolapse varies in severity from one person to another. Depending on the symptoms and how they affect your quality of life, your doctor will determine the most appropriate treatment, whether surgical or non-surgical. If no significant symptoms are present, treatment may not be necessary, but regular check-ups with your doctor are essential to monitor the condition.
However, if you experience troublesome symptoms, your doctor may suggest several treatment options tailored to your condition and the severity of the prolapse. These options may include:
• Lifestyle modifications
• Pelvic floor muscle exercises
• Vaginal pessary use
• Hormone therapy (estrogen) if necessary
• Surgery
If uterine prolapse is mild and doesn’t cause significant symptoms, some lifestyle adjustments can help prevent the condition from worsening, including:
• Losing weight if you are overweight
• Avoiding heavy lifting
• Steering clear of high-intensity exercises
• Eating a fiber-rich diet and drinking plenty of water to prevent constipation
• Quitting smoking
Kegel exercises help strengthen the pelvic floor muscles and can be effective in treating mild cases of uterine prolapse. To perform these exercises:
1. Tighten your pelvic floor muscles as if trying to stop passing gas or prevent urination.
2. Hold the contraction for 5 seconds, then relax for 5 seconds. If this is difficult, start with shorter durations and gradually increase.
3. Gradually extend the hold time to 10 seconds per contraction.
4. Repeat the exercise 10 times per session, and you can perform these exercises anywhere, up to 3-4 times a day.
A vaginal pessary is a ring-shaped device placed around the cervix to help lift and support the uterus. It is used for moderate to severe cases
IF UTERINE PROLAPSE IS MILD AND DOESN’T CAUSE SIGNIFICANT SYMPTOMS, SOME LIFESTYLE ADJUSTMENTS CAN HELP PREVENT THE CONDITION FROM WORSENING.
of uterine prolapse and is a good option if you prefer to avoid surgery. However, the pessary needs to be removed, cleaned, and replaced regularly.
If non-surgical treatments fail or if the prolapse is severe, surgery may be the most appropriate solution. Several types of surgeries are available to treat uterine prolapse, and the choice of surgery depends on the severity of the condition and your desire to have children in the future. These surgeries include:
This involves stitching the uterus back into place or strengthening the supporting tissues. It can be performed through the abdomen or vagina under general anesthesia. If you plan to become pregnant in the future, your doctor may advise delaying surgery, as pregnancy may cause the prolapse to recur.
Hysterectomy
If you are postmenopausal or do not wish
to have more children, your doctor may recommend a full hysterectomy.
This involves inserting a mesh to support the prolapsed organs, but its use has declined due to complications such as pain and nerve damage.
This option is reserved for advanced cases where there is no longer a desire for sexual activity. Part or all of the vagina is closed to relieve symptoms.
Free yourself from the discomfort of uterine prolapse and consult our specialized gynecologists at Al Ahli Hospital to find the best treatment option for you, whether surgical or non-surgical. Book your appointment now!
IF NON-SURGICAL TREATMENTS FAIL OR IF THE PROLAPSE IS SEVERE, SURGERY MAY BE THE MOST APPROPRIATE SOLUTION. SEVERAL TYPES OF SURGERIES ARE AVAILABLE TO TREAT UTERINE PROLAPSE, AND THE CHOICE OF SURGERY DEPENDS ON THE SEVERITY OF THE CONDITION AND YOUR DESIRE TO HAVE CHILDREN IN THE FUTURE.
The emergence of smart pharmacies is becoming increasingly significant in the healthcare sector, representing a modern approach to pharmaceutical care. By utilizing technology and artificial intelligence, these pharmacies enhance patient outcomes and streamline pharmacy operations.
The importance of smart pharmacies lies in their ability to improve efficiency, patient experience, medication safety, and regulatory compliance. Additionally, they provide datadriven analytics to support better healthcare outcomes. These pharmacies employ technologies such as artificial intelligence, automation, and advanced electronic devices to deliver more efficient and safer pharmaceutical services, offering tremendous potential to improve healthcare quality and reduce costs.
Smart pharmacies improve efficiency and accuracy by reducing human errors, speeding up service, enhancing data precision, customizing services, and improving communication among healthcare providers.
They use automated systems and technologies to streamline the medication dispensing process, minimizing errors and boosting operational efficiency. This allows pharmacists to focus more on patient care and providing consultations.
These automated systems simplify the dispensing procedures, reducing waste and increasing accuracy, which enables pharmacists to offer better advisory services to patients.
Integrated medication management systems in these pharmacies include comprehensive databases on drugs, interactions, and allergies, helping pharmacists make informed decisions and provide appropriate pharmaceutical consultations.
Moreover, these systems can be integrated with hospital and other healthcare center networks, facilitating information exchange and coordination among healthcare providers.
Smart pharmacies transform the patient experience from merely receiving medication
to a comprehensive, precise, fast, and effective experience. They enhance the patient’s experience and comfort by providing the ability to track medication orders, receive notifications, and communicate with pharmacists remotely.
Smart systems help minimize potential human errors in medication dispensing, ensuring that patients receive the correct medication in the appropriate dosage. Automation also speeds up the medication dispensing process, saving patients time and effort.
Patients also benefit from access to comprehensive information about their medication, such as usage instructions and potential side effects, through display screens or mobile applications.
Smart pharmacies can personalize services based on the patient’s medical history and health condition, and they facilitate communication between the pharmacist and the patient’s medical team to ensure safety and continuous health monitoring.
Smart pharmacies rely on advanced systems for effective and accurate drug inventory management, contributing to improved service quality and cost reduction. These systems use specialized software to track each drug in the inventory from the receipt date to the expiration date.
The systems in smart pharmacies integrate with hospital information systems (HIS) to provide real-time visibility into drug inventory levels, expiration dates, and usage patterns, enabling better inventory management and cost control. These systems collect and analyze data related to drug sales and consumption rates, helping predict future needs and avoiding drug shortages.
Automatic alerts are also sent to pharmacists when drug levels are low or expiration dates are near, allowing timely action. Inventory management in smart pharmacies depends on modern technology and integrated systems to achieve the highest level of accuracy and efficiency in drug management, thereby improving the quality of service provided to patients.
SMART PHARMACIES TRANSFORM THE PATIENT EXPERIENCE FROM MERELY RECEIVING MEDICATION TO A COMPREHENSIVE, PRECISE, FAST, AND EFFECTIVE EXPERIENCE. THEY ENHANCE THE PATIENT’S EXPERIENCE AND COMFORT BY PROVIDING THE ABILITY TO TRACK MEDICATION ORDERS, RECEIVE NOTIFICATIONS, AND COMMUNICATE WITH PHARMACISTS REMOTELY. SMART PHARMACIES CAN PERSONALIZE SERVICES BASED ON THE PATIENT’S MEDICAL HISTORY AND HEALTH CONDITION, AND THEY FACILITATE COMMUNICATION BETWEEN THE PHARMACIST AND THE PATIENT’S MEDICAL TEAM TO ENSURE SAFETY AND CONTINUOUS HEALTH MONITORING
Smart pharmacies play a crucial role in enhancing medication safety by providing a safe and accurate environment for drug dispensing. They use technologies such as automated dispensing cabinets to ensure medications are stored under ideal conditions and dispensed precisely according to physicians' instructions, thereby improving patient safety.
There are advanced computer systems to verify the accuracy of prescriptions and ensure there are no potential contradictions or drug interactions. Prescribed dosages are checked for suitability to the patient’s condition. These systems also help track the movement of medications from the moment they are received until they are dispensed to the patient. Patient identity is verified before dispensing medication using technologies like facial recognition or fingerprints. Smart pharmacies can interact with other healthcare systems, such as electronic patient records, to obtain more comprehensive information about the patient’s condition and
medical history. They can also record any side effects reported by patients, helping identify potential issues with medications and notifying the relevant authorities.
Data-driven analytics play a vital role in smart pharmacies, contributing to extracting valuable insights from available data, leading to better decision making and improved efficiency. By collecting and analyzing data from various touchpoints, smart pharmacies can provide valuable insights to healthcare providers and administrators, enabling them to make data-driven decisions and foster continuous improvement. Data-driven analytics contribute to transforming traditional pharmacies into smart entities capable of delivering more efficient and effective services. By leveraging available data, pharmacies can enhance the patient experience, increase operational efficiency, and discover new opportunities for improving healthcare.
SMART PHARMACIES CAN INTERACT WITH OTHER HEALTHCARE SYSTEMS, SUCH AS ELECTRONIC PATIENT RECORDS, TO OBTAIN MORE COMPREHENSIVE INFORMATION ABOUT THE PATIENT’S CONDITION AND MEDICAL HISTORY.
The healthcare landscape is undergoing a seismic shift as genomics and precision medicine converge, bringing a new era of personalized treatments. This transformation is particularly evident in the Gulf Cooperation Council (GCC) region, where biotechnology is rapidly becoming a leading market force.
In the past two decades, the field of genomics has advanced at an astonishing pace. The completion of the Human Genome Project in 2003 marked the beginning of a new era, making it possible to decode the genetic
THE COMPLETION OF THE HUMAN GENOME PROJECT IN 2003 MARKED THE BEGINNING OF A NEW ERA, MAKING IT POSSIBLE TO DECODE THE GENETIC BLUEPRINT OF LIFE.
blueprint of life. What was once a prohibitively expensive and time-consuming process can now be done quickly and affordably.
In the GCC, countries are racing to harness the power of genomics. Saudi Arabia’s Vision 2030, for instance, includes ambitious plans to bolster the biotechnology sector, with substantial investments in genomic research. These efforts aim to map the unique genetic makeup of the region’s population, paving the way for groundbreaking medical innovations.
Precision medicine takes the vast data generated by genomic research and translates it into tailored treatment plans. Unlike traditional approaches, which apply uniform treatments to all patients, precision medicine considers the unique genetic, environmental, and lifestyle factors of each individual.
This personalized approach is particularly promising in the GCC, where genetic disorders and chronic diseases are prevalent. By leveraging genomic data, healthcare providers can identify individuals at risk for conditions like diabetes, cardiovascular diseases, and certain cancers. Early detection and customized treatment plans can significantly improve patient outcomes and reduce healthcare costs.
The biotechnology sector in the GCC is experiencing unprecedented growth. Governments are not only funding research but also creating an environment conducive to innovation. The establishment of biotech startups and collaborations with international companies are driving this progress.
Take Qatar’s Sidra Medicine, for example. It’s at the forefront of integrating genomics into everyday clinical practice, focusing on the genetic underpinnings of diseases that are common in the region. Similarly, Saudi Arabia is making strides with its Vision 2030 initiative, aiming to establish itself as a global biotech leader.
The UAE is also making significant contributions. The Mohammed Bin Rashid University of Medicine and Health Sciences in Dubai is advancing genomic research with initiatives designed to integrate precision medicine into the national healthcare system. Additionally, Abu Dhabi’s Genome Program aims to sequence the genomes of the Emirati population, providing valuable data for developing personalized treatments and preventive healthcare strategies.
Despite the promising advancements, challenges remain. There’s a pressing need for a skilled workforce capable of handling sophisticated genomic data and translating it into clinical practice. Ethical considerations regarding the use of genetic information and ensuring that these advanced treatments are accessible to all segments of the population are also critical issues that need addressing. However, the GCC’s proactive stance on embracing biotechnology suggests that these challenges are surmountable. The integration of genomics and precision medicine holds the potential to revolutionize healthcare, improving patient outcomes and reducing the burden on healthcare systems.
The GCC’s investment in genomics and precision medicine is more than just a trend— it’s a strategic move to position the region at the forefront of global healthcare innovation. As these technologies continue to evolve, the potential for new discoveries and treatments is immense.
In conclusion, the rise of genomics and precision medicine is set to transform healthcare in the GCC. By unlocking the power of genetic information, the region is poised to lead the way in personalized healthcare, offering new hope for patients and driving the biotechnology market forward.
THE GCC’S INVESTMENT IN GENOMICS AND PRECISION MEDICINE IS MORE THAN JUST A TREND— IT’S A STRATEGIC MOVE TO POSITION THE REGION AT THE FOREFRONT OF GLOBAL HEALTHCARE INNOVATION. AS THESE TECHNOLOGIES CONTINUE TO EVOLVE, THE POTENTIAL FOR NEW DISCOVERIES AND TREATMENTS IS IMMENSE.
Dr. Ali Elhaj, CEO, Ardens Health
Patients who trust and feel understood by their providers are more likely to adhere to treatment plans, seek prompt medical care, and have better overall health. Given the clinical relevance of patientprovider relationships, it is surprising that they have only recently become the focus of empirical attention. This may be due partly to the fact that these relationships are difficult to define, quantify, and operationalize. Current practices around patient-provider relationships illustrate consistent patterns with respect to major barriers that prevent or hinder a strong relationship. Since communication is based more on how messages are sent and received rather than the actual words uttered, cultural interpretations may differ because provider and patient are not using a common language when they are receiving or sending messages.
Research shows potential future harms of referring to patients as customers. This shift in perspective to providing a customer-driven healthcare system may alter healthcare in ways that are not completely positive and might be influenced by efforts to market healthcare services to patients because patients could be viewed as consumers
and competitors. This change in provider mindset from "care provider" to "competitor" (in the minds of the patients) logically could have substantial, negative consequences for the profession and for patient care even if the provider actual "care upped its quality."
From a standpoint of patient care, the emphasis on "exceeding customer expectations" does not allow for the unfortunate circumstances of a patient's illness to take precedence over the patient's wants; when service providers focus exclusively on "Customer as King" instead of "Patient as Person," patients' autonomy can be threatened. From a moral and ethical standpoint, there are a number of bioethicists who raise concerns and ponder whether it is truly ethically appropriate to direct efforts towards targeting a particular, affluent market segment instead of utilizing valuable resources to provide treatments and aid where they are urgently required.
Conversely, perhaps healthcare does benefit from the "market forces" of the commercial sector today. While they are not "customers," even patients who do not have access to the commercial health complex anymore have the right to expect the same quality care. Thus, these "market forces" cause us to make sure we are the best. Thus, while healthrelated industries do not fit the model of typical for-profit enterprises, the tension between professionalism and customer orientation can be a creative force. Marketing and healthcare professionals in consultation with other stakeholders (such as bioethicists and healthcare policy makers) must frame the concept of the “patient” or “consumer” in ways that account for, even as they try to influence, all these complexities.
The patient-provider relationship has evolved due to changes in healthcare, shifting the patient's role to that of a partner in treatment and cooperation. Concerns about using "customer" in healthcare have been raised due to potential negative connotations and its association with commercialization. This shift can impact the ethical aspect of the provider-patient relationship. The inclination to treat a patient as a customer can lead to ambiguity, as the term "client" carries various social implications. Customers are considered moral entities in society, and labeling a patient as a customer doesn't alter the rules of the patient-provider relationship. Although terminating a transactional relationship with a customer is a choice, the same rules should not apply to patients, given providers' substantial responsibilities.
Steadfast Per formance
Independently operating chemistr y and immunoassay testing, Reagent load on the fly, rapid throughput, FlexMode Maintenance.
Single point of sample loading, one -tube testing and intuitive, guided operations .
Contribute to qualit y patient care through reliable result s across a broad Chemistr y and Immunoassay menu.
